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ABSTRACT 
An estimated 25 billion in US health care expenditure is spent on care of chronic, 
non-healing wounds. The failure to effectively heal wounds is often compounded by co-
morbidities, such as diabetes or obesity. Another major patient population afflicted with 
chronic wounds are the elderly. Advanced age is associated with a decline in 
immunologic function that contributes to a poor response to vaccination, infection and 
tissue injury resulting in prolonged hospital stays and age-related morbidity and 
mortality. Specifically, clinical observations and laboratory studies have suggested an 
age-related decline in cutaneous wound healing, marked by protracted wound closure, 
wound dehiscence and chronic wound states.  
Previous studies have suggested that age-related alterations in the early inflammatory 
phase of cutaneous wound injury may contribute to the lengthened and aberrant course of 
wound healing in the elderly. This impaired response to cutaneous injury offers a 
persistent portal of entry for foreign pathogens, such as Staphylococcus aureus (S. 
aureus), a common dermatopathogen that accounts for up to 50% of surgical site 
infections in the elderly. Underlying this elevated susceptibility to infection are deficits in 
host recognition, phagocytosis, migration and activation of a pathogen-specific adaptive 
immune response. Specific innate immune deficits have been tied to an elevated risk of S. 
aureus wound infection, including decreased neutrophil counts and function, reduced 
expression of cutaneous antimicrobial peptides and aberrant toll-like receptor 2 (TLR2) 
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expression and/or signaling. However, the effect of age on these specific alterations in 
the innate response has not been well described in a model of cutaneous wound infection. 
Thus, we hypothesized that advanced age contributes to a functionally inept innate 
immune response that impairs resolution of S. aureus cutaneous wound infection.  
To elucidate the effects of advanced age on cutaneous wound infection, the specific 
aims were  (i) To establish a model of local cutaneous wound infection in young and aged 
mice, (ii) To determine if age-related changes in leukocyte phagocytosis, leukocyte 
recruitment or cutaneous antimicrobial peptide expression contribute to age-associated 
differences in bacterial colonization and wound closure (iii)To determine if modulation 
of these age-associated deficits in the early innate response to S. aureus cutaneous wound 
infection may provide new therapeutic avenues for treating wound infection and 
promoting wound closure in the elderly.  
Aim 1 was to establish of model of cutaneous injury and S. aureus infection in young 
(3-4 month) and aged (18-20 month) BALB/c mice. Following injury and infection at 
days 1-10, we observed heightened bacterial colonization and delayed wound closure in 
aged animals as compared to young. 
In Aim 2, we utilized this model to evaluate keratinocyte and resident leukocyte TLR 
expression, leukocyte infiltration and phagocytosis and wound antimicrobial peptide 
expression. While no differences in infiltrating leukocyte TLR expression, phagocytosis 
or antimicrobial peptide expression were noted, decreased neutrophil and macrophage 
recruitment to the wound site were observed in aged mice relative to young. In an in vivo 
 xv 
chemotaxis assay, we confirmed a reduced migratory capacity to increasing doses of the 
neutrophil chemokine KC in aged mice. 
Given these findings, we sought to modulate neutrophil recruitment to the wound site in 
Aim 3. Following cutaneous injury and infection, mice either received 3 s.c. injections of 
250 pg of G-CSF or saline vehicle. G-CSF treatment in aged mice reduced bacterial 
colonization and wound size relative to saline controls. This was associated with 
increased neutrophil accumulation in wounds of aged, G-CSF treated mice at days 3 and 
7 following injury and infection. While future work needs to be conducted to elucidate 
the mechanism by which G-CSF exerts these age-dependent effects, our data highlights a 
putative indication for G-CSF treatment within the wound care setting in the elderly 
patient population as well as patients with local or systemic neutropenia.
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CHAPTER 1 
INTRODUCTION 
 Advanced age is associated with a decline in immunologic function that 
contributes to a poor response to vaccination, infection and tissue injury resulting in 
prolonged hospital stays and age-related morbidity and mortality. Specifically, clinical 
observations and laboratory studies have reported an age-related decline in cutaneous 
wound healing, marked by protracted wound closure, wound dehiscence and chronic 
wound states. Previous studies have suggested that age-related alterations in the early 
inflammatory phase of cutaneous wound injury may contribute to the lengthened and 
aberrant course of wound healing in the elderly. This impaired response to cutaneous 
injury offers a persistent portal of entry for foreign pathogens, such as Staphylococcus 
aureus (S. aureus), a common dermatopathogen that accounts for up to 50% of surgical 
site infections in the elderly. Specific innate immune deficits have been tied to an 
elevated risk of S. aureus wound infection, including decreased neutrophil counts and 
function, reduced expression of cutaneous antimicrobial peptides and aberrant Toll-like 
receptor (TLR) 2 expression and/or signaling. However, the effect of age on these 
specific alterations in the innate response has not been well described in a model of 
cutaneous wound infection. Thus, we hypothesize that advanced age contributes to a 
functionally inept innate immune response that increases the susceptibility to cutaneous 
wound infection with S. aureus. To elucidate the effects of advanced age on cutaneous 
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wound infection, the specific aims of this proposal are (i) To establish a model of local 
cutaneous wound infection in young and aged mice, (ii) To determine if age-related 
changes in leukocyte phagocytosis, leukocyte recruitment or cutaneous antimicrobial 
expression contributes to age-associated differences in bacterial colonization and wound 
closure (iii)To determine if modulation of these age-associated deficits in the early innate 
response can enhance resolution of S. aureus wound infection in aged animals. Overall, 
this project will potentially reveal age-specific alterations in the innate immune response 
to cutaneous wound infection that may provide novel treatment options, ultimately 
improving clinical outcomes in the elderly. 
 
Hypothesis: Impaired function of innate immune leukocytes and cutaneous antimicrobial 
peptides delays resolution of cutaneous wound infection with advanced age. 
 
Aim 1: To establish a model of cutaneous S. aureus wound infection in young and aged 
mice. 
Aim 2: To determine age-related alterations in innate immunity that may contribute to 
differences in bacterial colonization and wound closure with advance age. 
Subaim 2A: To determine if an age-related impairment of phagocytosis and/or 
bactericidal activity promotes delayed resolution of wound infection 
in aged mice. 
Subaim 2B: To evaluate leukocyte recruitment and factors involved in leukocyte 
infiltration that may contribute to differences in bacterial burden and 
wound closure in aged mice. 
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Subaim 2C: To examine if age-associated differences in cutaneous antimicrobial 
peptide expression contribute to heightened bacterial colonization and 
reduced wound healing in aged mice. 
Aim 3: To determine if local, subcutaneous treatment with granulocyte-colony 
stimulating factor (G-CSF) can enhance resolution of cutaneous wound infection 
in aged mice. 
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CHAPTER 2 
REVIEW OF RELATED LITERATURE 
Aging, life expectancy and healthy living years 
Health care advancements have contributed to a constant, linear increase in the 
expected lifespan in developed countries. In 1950, the probability of survival to 80-90 
years of age was 12-16% and had doubled to 25-37% by 2002 (1). Interestingly, life 
expectancy data from the last century suggests that we have yet to reach the limits of 
human longevity (1), supporting the concept that the proportion of our population 
considered elderly, or over 65, will increasingly comprise a greater percentage of our 
population as a whole. Despite advances in health care that have improved human 
lifespan, our healthy living years are still limited by diseases that compromise activities 
of daily living and cognition. It has been reported that disease prevalence has grown in 
the aging population over time (1). While improved detection may account from some of 
the increase in disease prevalence, diabetes, obesity, cancer and heart disease have all 
risen markedly in the elderly. Of note, a dichotomy in the aging population is observed. 
Some individuals are able to maintain daily living activities, ward off infection and do 
not develop severe autoimmune or malignant conditions. Another sub-population, often 
referred to as the “frail” elderly, lose the ability to maintain clinical measures of 
independent living (i.e. management of medication, transportation, preparation of meal, 
etc.) and their physical deterioration is often marked by infection and significant 
pathology (1, 2).  Given the seemingly unimpeded growth of the aging population, efforts 
to reduce chronic disease and improve healthy living years will greatly improve quality 
of life measures and curb the predictable strain on already unstable medical care systems. 
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A better understanding of the mechanisms that play a role in healthy and frail aging are 
critical to expanding healthy living years in the elderly and may help stifle a growing 
public health predicament.  
 
Aging and Innate Immunity 
A predominate contributing factor to these clinical ailments is dysfunction of the 
immune system. In particular, dysregulation of the innate immune response contributes 
directly to aging pathologies, as well as indirectly by altering activation of the adaptive 
arm of the immune response. In aged individuals, there is a paradoxical activation of 
baseline inflammation referred to as “inflamm-aging” coupled with a refractory response 
to immune challenge known as “immunosenescence” (reviewed in (3-6)). With advanced 
age, the inability to balance pro- and anti-inflammatory responses generates a basal 
elevation in pro-inflammatory mediators that may blunt appropriate innate and adaptive 
cellular immune activation and function (Figure 1). This disrupted balance between 
inflammation and immune activation may contribute to a variety of co-morbidities and 
increased mortality following both local and systemic insults (7-11).  Herein, we discuss 
how aging negatively impact the host immune response and clinical outcomes by 
impairing three innate immune mediators: antimicrobial peptides, neutrophils and 
macrophages.  
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Figure 1.  The skewed balance of the aging innate immune system. Advanced aged is 
marked by a heightened, basal pro-inflammatory response termed “inflamm-aging” that it 
built upon genetic, epigenetic and hormonal age-associated changes. Additionally, 
following antigenic challenge or systemic insult, immune cells from the elderly 
demonstrate an immunosenescent phenotype. Together, this results in greater morbidity 
and mortality following trauma or infection. Modified from (12). 
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Antimicrobial Peptides 
Antimicrobial peptides (AMPs), such as defensins and cathelicidins, are small 
cationic molecules that are able to promote bacterial killing via interactions with the 
bacterial membrane, leading to membrane destabilization and bacterial lysis (13, 14). 
Several families of AMPs have been identified, including -defensins, -defensins, 
cathelicidins and the Reg family of AMPs. Over the past few years, these small 
molecules have garnered increasing attention for their bactericidal properties and 
modulation of wound healing (15-18). In addition to their bactericidal potential, AMPs 
are also known to be directly chemotatic for neutrophil and macrophages, highlighting 
their importance in regulation of the innate immune response (13, 19). However, very 
little has been published regarding the impact of advanced age on this innate immune 
subset. One study has reported that cathelicidin related antimicrobial peptide (CRAMP) 
mRNA expression was 10-100 fold higher in skin from neonatal mice as compared to 
adult mice, however aged animals were not examined (20). In another study, 
immunostaining for CRAMP and mouse -defensin 3 (mBD3) in intact epidermis 
revealed reduced CRAMP levels in epidermal cells from 15-18 month aged mice as 
compared to young animals (21). However, levels of mBD3 in these aged animals were 
increased relative to young controls (21). Given the important immunomodulatory and 
host defense properties of these small molecules, further work to evaluate how they are 
impacted by age is warranted. 
 
 
8 
 
Neutrophils 
Alongside AMPs, neutrophils are a critical first line of defense for the innate arm 
of the immune system in response to infectious challenge. Swift recruitment and 
activation of neutrophils occurs via integration of several, successive signaling steps 
involving selectins, integrins, chemokines and G protein coupled receptors (22, 23). The 
primary chemotatic signals for neutrophils in mice are KC and macrophage inflammatory 
protein-2 (MIP-2), both human interleukin (IL) -8 functional homologs. Other signals 
included complement factor C5a and leukotriene B4. KC and MIP-2 interact with the 
neutrophil chemoattractant receptor CXCR2 to initiate intracellular signaling pathways 
involved in neutrophil chemotaxis (24, 25). Specifically, downstream of CXCR2, 
activation of the small GTPase Ras-related protein 1 (Rap1) has been show to be crucial 
in mediating adhesion by regulation of two integrins, lymphocyte-function associated 
antigen-1 (LFA-1: CD11a/CD18) and very late antigen-4 (VLA-4: CD49a/CD29; 26-28). 
Rap1-induction of integrin activity occurs via several convergent pathways downstream 
of CXCR2; however, the canonical pathway involves activation of phospholipase C 
(PLC; (26, 27, 29, 30). This upregulation of selectins and integrins promotes loose rolling 
followed by firm adhesion mediated by interactions with intracellular adhesion molecule-
1 (ICAM-1) and vascular cellular adhesion molecule-1 (VCAM-1) present on activated 
endothelium. Firm adhesion coupled with apically suspended chemokines promotes 
neutrophil diapedesis to the site of injury or infection (Figure 2). 
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Figure 2. Neutrophil chemotaxis. Following cutaneous injury and infection, resident 
immune cells and keratinocytes release a host of soluble factors to initiate the innate 
immune response. In mice, release of the chemokines KC and MIP-2 act to recruit 
neutrophils by diffusing across endothelial cells to interact with their chemokine receptor, 
CXCR2, on peripheral blood neutrophils. Ligation of CXCR2 results in activation of PLC 
and Rap-1 to promote upregulation and clustering of selectins and integrins that help 
mediate (1) loose rolling followed by (2) firm adhesion via interaction with ICAM-1 and 
VCAM-1 on activated endothelium. In response to apically suspended chemokines, 
neutrophils can then undergo (3) diapedesis to the site of injury and infection.  
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Upon their recruitment, neutrophils act to clear invading microbes and debris by 
phagocytosis and intracellular killing mechanisms involving the generation of reactive 
oxygen species (ROS) and degranulate to release a variety of antimicrobial peptides, pro-
inflammatory cytokines and hydrolytic enzymes (31-34)(35). Neutrophil granules contain 
multiple antimicrobial molecules and proteases including elastase, cathepsins, matrix 
metallopeptidase-9 and human neutrophil peptide-1 (34). Binding of pathogen-associated 
molecular patterns (PAMPs), such as formyl-Methionyl-Leucyl-Phenylalanine (fMLP), 
lipopolysaccharide (LPS) and other toll-like receptor (TLR) and triggering receptor 
expressed on myeloid cells-1 (TREM-1) ligands, to pattern recognition receptors (PRRs) 
promotes neutrophil activation. Cytokines including granulocyte-macrophage colony-
stimulating factor (GM-CSF), interleukin (IL)-15 and IL-18, can also prime neutrophils 
resulting in delayed or decreased apoptosis which subsequently lead to enhanced 
neutrophil effector functions (36-38). Activated neutrophils can then release cytokines 
and chemokines such as tumor necrosis factor- (TNFα), IP-10, macrophage 
inflammatory protein-1α (MIP-1α), IL-12, KC, MIP-2, vascular endothelial growth factor 
(VEGF) among others to help drive the subsequent immune response (39).  
In addition to pathogen recognition and inciting an inflammatory response, 
neutrophils play a critical role in clearance of invading pathogens. One mechanism for 
removal of foreign pathogens is the Fragment, crystallizable gamma receptor (FcR)-
mediated phagocytosis pathway (Figure 3). An invading organism is recognized by one 
of three FcR (CD16, CD32 or CD64) and is internalized in a Ras-related C3 botulinum 
toxin substrate 2 (Rac2)-dependent manner. Activation of Rac2 , a small GTPase, 
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promotes interaction with cytosolic p67
phox
 to form and recruit the nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase complex to the maturing phagosome to 
mediate bactericidal functions (32, 40-42). Defects in the NADPH oxidase system, such 
as in chronic granulomatous disease, are associated with increased susceptibility and 
recurrent bacterial infections (43).  
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Figure 3. Neutrophil phagocytosis and assembly of the NADPH oxidase complex. 
Neutrophils play a critical role in clearance of foreign pathogen via FcR-mediated 
phagocytosis. Following interaction between the FcR and a pathogen, internalization 
and activation of the small GTPase Rac2 promotes interaction of the cytosolic p67
phox
 
complex with membrane bound p22 and gp91. Together, the NADPH complex is then 
guided to the maturing phagosome to help generate ROS and promote bactericidal 
activity.  
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Numerous studies in human and rodent models suggest that aging alters the 
circulating neutrophil pool and negatively impacts neutrophil effector functions, and that 
these changes can be amplified in the setting of trauma, infection and tissue injury (5, 44-
52). With increased aged, there is a shift in the hematopoietic stem cell (HSC) pool 
towards generation of myeloid lineage cells, including neutrophils (reviewed in (53)). To 
extend these findings, Miyamoto et al. examined the impact of forkhead box O3a 
transcription factor (FoxO3a) in regulation of HSC differentiation in aged mice (54).  The 
family of FoxO transcription factors mediate many cellular processes (55), and has been 
shown to be a player in HSC differentiation via modulation of oxidative stress (55). 
Considering the contribution of oxidative stress to immune dysregulation with age 
(reviewed in (56)), the impact of this particular pathway in the maintenance of the 
circulating neutrophil pool is of interest. Data from this group demonstrated that during 
recovery from myelosuppressive treatments, aged FoxO3a deficient mice exhibited 
profound neutrophilia compared to young knockout mice (54). This increase in 
neutrophils was associated with loss of inhibition of FoxO3a on Sprouty-related 
Ena/VASP homology 1 domain containing proteins 2 (Spred2), a negative regulator of 
cell proliferation, as well as activation of AKT and extracellular signal-related kinase 
(ERK) in the aged knockouts. This study provides a novel insight into maintenance of the 
HSC pool in aging, and extensions of these studies to examine the affect of age on 
expression of the FoxO family of transcription factors may further characterize the 
hematopoietic disruption and altered neutrophil development and function observed in 
aged animals.  
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Trauma and Tissue Injury 
In the setting of systemic insults, such as those seen following traumatic injury or 
sepsis, an over-exuberant neutrophil response may contribute to the systemic immune 
response syndrome, and the associated morbidity and mortality in aging patients (57-59). 
Since the age of the patient is a major clinical predictor of outcome following trauma, 
several murine studies have investigated how neutrophils as early immune mediators may 
be contributing to poor clinical outcomes after major trauma and tissue injury (11, 48-
50). Our laboratory has previously shown that aged mice exhibit increased mortality 
following a 15% total body surface area full-thickness burn trauma as compared to young 
mice subjected to the same injury (11). These aged mice have elevated levels of the 
neutrophil chemokine KC in lung tissue which translated into heightened neutrophil 
infiltration and pulmonary inflammation 24 hours following burn injury (48). 
Administration of anti-CXCR2 antibody in aged mice reduced levels of neutrophil 
accumulation and pulmonary inflammation to levels observed in young mice (48), 
perhaps suggesting that modulating the neutrophil response following systemic insult 
may decrease pulmonary co-morbidities. Extending these studies, we observed that 
expression of endothelial ICAM-1 was elevated on the pulmonary endothelial cells 
following burn injury in aged mice as compared to young, suggesting that the age-related 
changes in the pulmonary vasculature that wound impact neutrophil extravasation with 
advanced age (60). These data are supported by reports that neutrophils from elderly 
donors demonstrated increased adherence to an endothelial cell monolayer following 
fMLP or phorbol 12-myristate 13-acetate (PMA) stimulation (61). However, two other 
studies determined that neutrophil adhesion to endothelial cells, expression of adhesion 
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molecules and neutrophil recruitment were comparable between young and aged donors 
(46, 62). These studies highlight differences not only between human and murine models, 
but also highlight how aging can exacerbate differences between neutrophil responses 
prior to and post injury.  
In the setting of local tissue injury, alterations in neutrophil infiltration may also 
play a role in delayed resolution with advanced age. Following cutaneous tissue injury, 
neutrophils are the first phagocyte to enter the wound bed, helping to incite an 
inflammatory response against invading organisms. In aged BALB/c mice, Swift et al. 
observed a significant delay in wound closure as reported in other studies (49, 50, 63, 
64). Though age-related differences in neutrophil recruitment to the site of cutaneous 
injury were observed at early time points, they did not reach significance (50). 
Conversusly, Nishio et al. demonstrated that neutrophil peak infiltration was delayed in 
aged C57BL/6 mice following cutaneous injury (49). Moreover, Gr-1 mediated 
neutrophil depletion further delayed wound closure in aged mice. Systemic 
administration of G-CSF or topical application of peritoneal-derived neutrophils from 
young mice restored rates of wound closure to those observed in young mice (49).  This 
reduced neutrophil chemotaxis with advanced age is recapitulated in ex vivo murine and 
human studies. In BALB/c mice, we recently reported that neutrophils from aged mice 
demonstrate a hyperchemokinesis in the absence of a neutrophil chemotatic stimulus; 
however, in the presence of increasing doses of KC, neutrophils from aged mice 
demonstrate a marginal chemotatic response as compare to neutrophils from young mice 
(60). Similarly, peripheral blood neutrophils isolated from healthy, aged subjects 
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conforming to the SENIEUR protocol demonstrated reduced migration towards fMLP 
and GM-CSF (45).  
Though fetal or adult wound healing studies often consider neutrophil recruitment 
detrimental to wound closure and scar formation (65), these studies highlight how 
findings in young model organisms are not always directly applicable to the aged 
organism. Moreover, the differing results in these between human and rodent studies 
reflect a major caveat in aging research. Namely, contradictory results between human 
and rodent studies can make it difficult to draw parallels between these studies, and 
future animal models need to closely mimic clinically relevant scenarios to improve the 
correlation between these data sets. Additionally, different animal strains can lead to 
alternative outcomes, further complicating rodent research models.  Future in vivo rodent 
models and injury paradigms should be evaluated to determine their relative correlation 
with findings in human studies to optimize rodent aging research. Though additional 
studies need to be conducted to better establish the role of neutrophils in wound healing 
and trauma, the impact of advanced age on neutrophil infiltration kinetics and function 
may contribute to adversus clinical outcomes such as suboptimal healing and infectious 
complications in the elderly.  
 
Infection and Environmental Exposures 
Neutrophils are critical for effective recognition and removal of debris and 
foreign pathogens. A major pathway that aids in recognition of non-native particles is the 
TLR pathway. In humans, aging does not impact basal levels of TLR2 and TLR4 
expression on neutrophils  (45). However, aging does increase neutrophil TLR4 
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expression in unstimulated lipid rafts and non-raft fractions compared to the young mice. 
Stimulation with the TLR4 ligand LPS markedly induced TLR4 recruitment to lipid rafts 
in young mice; however, aged mice did not alter recruitment or redistribution of TLRs 
between lipid raft and non-raft fractions (45).  Expression of MyD88, a common 
downstream signaling molecule of several TLRs, on neutrophils isolated form young and 
aged mice was comparable after LPS stimulation. Interestingly, in the same study, 
parallel work in human neutrophils demonstrated reduced membrane-associated MyD88 
in neutrophils from aged subjects after stimulation (45).  
Similar to difference in membrane/raft-associated TLRs and MyD88, TREM-1 
localization to lipid rafts was decreased with age following exogenous stimulation and 
this correlated with reduced TREM-1-induced neutrophil functions including 
degranulation, phagocytosis, ROS production and production of pro-inflammatory 
cytokines and chemokines (66). Of note, elevated circulating levels of soluble TREM-1 
are associated with heightened inflammation as well as morbidity and mortality in 
critically ill patients with sepsis (67). In addition to TREM-1, Fc receptors play a 
predominate role in neutrophil phagocytosis and ROS generation. Studies in neutrophils 
isolated from healthy, elderly subjects demonstrate decreased FcRIII expression (CD16), 
and this correlated with reduced phagocytic potential. Together, these data suggest a 
potential for reduced pathogen recognition, phagocytosis and bactericidal potential with 
age that may negatively impact outcomes following bacterial or viral infection in aging 
subjects. 
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The studies mention above primarily focused on ex vivo stimulation of neutrophils 
to generate age-dependent changes in neutrophil effector functions. To extend these 
studies, others have examined the impact of age on neutrophil function in in vivo models 
of infectious challenge or environmental exposures (51, 52, 68-70). In one such study in 
aged mice, exacerbated LPS-induced pulmonary inflammation was correlated with 
increased lung levels of KC, MIP-2, IL-1 and prolonged pulmonary neutrophilia at 72 
hours (70).  In another model of pulmonary challenge, intranasal infection with 
Francisella tularensis lead to an altered lung inflammatory response, with a delay in 
production of neutrophil chemokines MIP-2 and CXCL6 and attenuated neutrophil 
infiltration into the lung tissue in aged mice (51). Moreover, environmental insults, such 
as air pollutants or cigarette smoke, contribute to airway inflammation and chronic 
pulmonary co-morbidities (71, 72). Aged mice subjected to inhaled diesel exhaust 
demonstrate enhanced pulmonary congestion and neutrophilia 24 hours after exposure as 
compared to young mice (52). Similarly, single or chronic cigarette smoke exposure in 
aged mice resulted in elevated levels of KC and MIP-2, and prolonged neutrophil 
recruitment to the lung (73).  This age-related increase in cytokine production was 
associated with amplified nuclear factor (NF)-B expression and nuclear translocation 
(73). Looking at these findings, in response to pulmonary challenge, aged mice have an 
elevated and/or prolonged neutrophil response. Considering the delicate lung alveolar 
architecture and the highly hydrolytic enzymatic degranulation products of activated 
neutrophils, this may contribute to excessive tissue damage and reduced lung function 
over time. 
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The role of neutrophils in other models of infection have also garnered interesting 
data. Following oral infection with Salmonella Typhimurium, aged mice have elevated 
bacterial colonization in the ileum, colon, Peyer’s patches, mesenteric lymph nodes 
(MLN) and liver as compared to young mice (68). Despite a baseline elevation in 
neutrophil numbers in the spleen and MLN of aged mice, aged mice did not increase 
neutrophil numbers in response to infection whereas young mice mounted a more 
significant neutrophil response (68).  Following challenge with the fungal pathogen 
Candida albicans, decreases in neutrophil recruitment to the peritoneal cavity were 
associated with reduced fungicidal activity in aged mice (74), again highlighting how 
neutrophil recruitment may be dysregulated with advanced age.  
Combined, these studies offer significant evidence suggesting that neutrophil 
recognition, phagocytic potential and infiltration kinetics are dysregulated with aging. 
This dysfunction may have pleiotropic effects on the host depending on the inciting 
injury or clinical paradigm by promoting pathogen dissemination, compromising organ 
function and delaying time to recovery. While altered neutrophil pathogen recognition, 
infiltration and phagocytosis may impair the ability of the innate immune response to 
contain microbes to site of origin, prolonged neutrophilia can result in significant tissue 
damage and inflammation via potent neutrophil hydrolytic enzymes, demonstrating the 
importance in precise temporal regulation of this particular immune cell subset.  
Macrophages 
 Macrophages play pivotal roles in modulating immune and stromal cell function 
following infection, tissue injury and in tumor cytotoxity (75-77). Following 
extravasation from the peripheral blood pool, monocytes undergo maturation into tissue 
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macrophages. As professional antigen presenting cells, macrophages help shape the 
innate and adaptive immune responses through the release of a variety of pro-
inflammatory mediators at early time points following injury or infection. Collaboration 
of macrophages with T and B cells is further mediated by the release of cytokines, 
chemokines, enzymes, arachidonic acid metabolites and reactive radicals (78, 79). 
Macrophages also serve to dampen the inflammatory response through phagocytosis of 
apoptotic cells and secretion of soluble factors like IL-10 (80). Age-related alterations 
in macrophage number and function have been correlated with enhanced susceptibility 
to infection, differential responses to tissue injury and enhanced tumor progression in 
rodent models (74, 81-83). 
 
Macrophage Population Dynamics 
With age, there is some discrepancy regarding changes in innate and adaptive 
immune cell numbers in rodent and human studies (68, 83, 84). In circulation, the number 
of blood monocytes in aged and young subjects appears to be comparable; however, there 
is a significant decrease in macrophage precursors as well as macrophages in the bone 
marrow of the elderly (85, 86). This may be related to a longitudinal decrease in 
macrophage bone marrow production over the human lifespan as a decrease in the 
percentage of cells expressing the CD68
+
 cells, a macrophage marker, was observed in 
bone marrow from adults as compared to children (86). In murine studies, one report 
suggests that there is an increase in the Mac1/CD11b population in aged murine bone 
marrow (87), though others have found there were no differences in the number or DNA 
content of developing macrophages between young and aged mice (84). In other cellular 
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compartments, aged mice have been reported to have increased resident macrophages in 
the spleen (68), though there is a reduction in the marginal zone macrophage population 
and a breakdown of the marginal zone architecture with advanced age (83). This collapse 
in marginal zone structure may impair clearance of circulating pathogens and follicular 
responses in the elderly, increasing susceptibility to infection and prolonging recovery. 
Though human and rodent studies have yet to generate a conclusive answer regarding 
macrophage numbers in various compartments, alterations in macrophage environmental 
distribution may generate organ specific dysregulation. For example, increased 
infiltration of macrophages into adipose tissue of aged C57/BL6 mice fed high caloric 
diets was associated with increased inflammasome activation and cytokine production 
(88). These data suggest that a tissue-specific shift in macrophage populations can 
contribute to basal differences in the inflammatory profile of aged individuals.  
 
Cytokine Production and TLR Signaling 
In rodent models, advance aged is associate with increased levels of circulating 
cytokines, in particular IL-6, and it has been speculated that changes in these pro-
inflammatory mediators may alter immune function in aged animals (11, 89-91).  
Despite this basal elevation, challenge of bone-marrow derived macrophages with 
Porphyromonas gingivalis (P. gingivalis) produce significantly less tumor necrosis 
factor- (TNF-and IL-6 in aged mice (92). The influence of aging on LPS-mediated 
cytokine production selectively impact macrophage responses, such that some functions 
are depressed while others are elevated. For example, macrophages from aged mice 
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have increased levels of cyclooxygenase-2 and produced elevated levels of 
prostaglandin E2 and IL-10 after LPS stimulation (93-95), whereas TNFα, IL-6 and IL-
1 and IL-12 production are decreased as mentioned above. Similarly, in response to 
LPS, splenic macrophages from aged wild type mice demonstrated diminished 
responsiveness to LPS stimulation, producing lower levels of TNF-, IL-1, IL-6 and 
IL-12 as compared to young controls (96). Interestingly, cytokine production was 
restored following in vitro culture of LPS with splenic macrophages from aged IL-6 
deficient mice (96), suggesting that elevated systemic IL-6 may directly impair 
macrophage function in aged animals. Several studies also support a similar reduction 
in cytokine production, including TNF-, IL-6, IFN-, nitric oxide (NO), monocyte 
chemoattractant protein-1 (MCP-1) and MIP-1, following a variety of stimuli (68, 74, 
92, 97).   
Generation of cytokines is often examined following stimulation of a variety of 
TLRs. TLRs help initiate the innate immune response to a variety PAMPs, and signal 
through either MyD88-dependent or –independent pathways to promote NF-B pro-
inflammatory cytokine production. Reduced expression of these receptors, or 
alterations in their respective downstream pathways, can increase susceptibility to 
infection (98-100), and a number of studies demonstrate alterations in the macrophage 
TLR expression and/or signaling in aged animals and humans. In both splenic and 
peritoneal macrophages of aged C57/BL6 mice, decreased expression in all TLRs 
(TLR1-9) have been found (74, 101), though other studies report no difference in 
expression of some TLRs, including TLR2 and TLR4, in aged BALB/c (82, 102, 103).  
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A study of 159 young and aged individuals found an age-associated reduction in TNFα 
and IL-6 by peripheral blood monocytes after stimulation with TLR1/2 that correlated 
with reduced surface expression of TLR1 (104). An age-associated decrease in TLR4 
surface expression and and TLR7-induced IL-6 production was also observed in this 
study (104). Recent research provided similar evidence for age-associated defects in 
TLR function in human macrophages in the context of infection with West Nile virus 
(99).  
While divergent results regarding TLR expression may be due to purity of the 
isolated macrophage population or murine background strain, the pathways downstream 
of TLRs may also be impaired with age. In one such study, LPS or zymosan induced 
TNF- and IL-6 production was attenuated in splenic macrophages from aged mice due 
to reduced activation of p38 mitogen-activated protein kinase (MAPK), MAPK-
activated protein kinase-2 and NF-B (102). Others have shown that thioglycollate-
elicited peritoneal macrophages from aged mice exposed to P. gingivalis have increased 
gene expression of the single immunoglobulin interleukin-1-related receptor (SIGIRR) 
which acts to inhibit TLR MyD88-dependent signaling (103, 105).  In aged rodent 
models, downregulation of other members of these pathways, like MyD88 and tumor 
necrosis factor receptor-associated factor 6 (TRAF6), lead to decreased activation of the 
NF-B family of transcription factors (69, 106).  While studies have shown that age 
does not affect the basal levels of LPS-binding protein (96), levels of CD14, a co-
receptor for TLR2 and TLR4, were reduced in macrophages from aged mice (107). 
Downregulation of mediators of the TLR pathways would dampen the immune 
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response, and may account for the decrease in cytokine production seen in aged rodent 
and human macrophages following immunogenic challenge. 
 
ROS/RNI Generation and Macrophage Phenotype 
Another major mediator of macrophage effector function is the generation of 
ROS and reactive nitrogen intermediates (RNI) that aid in intracellular microbicidal 
activity and tumor cytotoxicity. ROS and RNI, alongside IL-1, IL-12, TNF-, represent 
the pro-inflammatory M1 macrophage profile, and these cells function in driving Th1 
responses, resisting tumor development and killing of intracellular foreign pathogens 
(80). On the other hand, M2, or anti-inflammatory, macrophages have elevated levels of 
IL-10 and arginase expression. M2 macrophages predominately function in 
immunoregulation, neovascularization, tissue remodeling and tumor growth (80, 108). 
Macrophages from aged mice had been shown to produce elevated levels of IL-10 and 
reduced FasL, IL-12 and TNF-, mediators that contribute to an M2 anti-inflammatory 
profile (109). Several studies have also reported decreases in ROS or RNI generation 
with age that may represent a skewing of M1 and M2 polarization with age (81, 110, 
111). As compared to young animals, alveolar macrophages from senescent rats 
demonstrated a decreased baseline generation of ROS and NO, and LPS treatment did 
not significantly change ROS and NO production in aged animals (110). In response to 
PMA or zymosan, peritoneal macrophages from aged mice produce 50% less hydrogen 
peroxide (H2O2) in contrast to cells from young animals (111). These studies are 
supported by previous reports in which NO production by splenic or peritoneal 
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macrophages was reduced in several mouse strains following LPS or peptidoglycan-
polysaccharide (112). In addition to these findings, macrophages from aged mice 
exhibit reduced GM-CSF mediated cell proliferation following exposure to H2O2 due to 
diminished signal transducer and activator of transcription (STAT) 5a oxidation and 
phosphorylation, suggesting that aging increases macrophage susceptibility to oxidative 
stress (113). 
NO production is modulated by enzymatic activity of inducible nitric oxide 
synthase (iNOS) via activation of the interferon-gamma (IFN- receptor. In aged 
BALB/c mice, mRNA expression of iNOS was found to be decreased after stimulation 
with LPS as compared to young mice (112). Similarly, our laboratory has observed 
decreased iNOS expression in splenic adherent cells from aged BALB/c mice following 
stimulation with IFN- and TNF- (114). As macrophage signaling through the IFN- 
receptor promotes ROS and RNI generation, several studies examined if alterations in 
this receptor and the downstream signaling pathway may exist with advanced age (111, 
115, 116). Though there are no differences in IFN- receptor with age (111, 115), 
culture with IFN- reduced H2O2 and NO2
-
 production in aged animals due to decreased 
phosphorylation of MAPK (111). Others also found decreased STAT1a gene and 
protein expression and reduced STAT1 phosphorylation after in vitro IFN- stimulation 
of macrophages isolated from aged BALB/c mice (115).  While this reduction in iNOS 
and NO production may suggest suppression of M1 macrophages with age, our lab has 
also observed a reduction in arginase-1 expression after IL-4 stimulation in adherent 
splenocytes from aged mice (114), implying a global immunosuppression of 
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macrophage function with age. Together, these studies suggest that the ROS and RNI 
pathways are dysregulated with age, translating into potential differences in 
macrophage phenotype and intracellular killing capacity, and ultimately negatively 
impacting immune function in the elderly. 
Contrary to these reports, Chen et al. found enhanced NO production in both 
thioglycollate-elicited and resident peritoneal macrophages from inbred CBA/CA aged 
mice following culture with LPS, zymosan or heat-killed S. aureus (117). In these 
animals, elevated NO production was correlated with a persistent increase in iNOS 
expression. Yet another study found no difference in iNOS induction, NO production or 
intracellular killing in thioglycollate-elicited macrophages from aged BALB/cByJ mice 
in response to in vitro stimulation with P. gingivalis (103). These studies highlight that 
a variety of factors, including the murine strain, macrophage population and inciting 
stimuli, all play are role in determining potential age-related differences in macrophage 
function in rodent models. 
 
Tissue Injury 
As temporal changes in macrophage phenotype have been implicated in wound 
resolution, alteration in macrophage phenotype and function in aged animals may 
provide insight into altered tissue repair with advanced age (50, 64, 118). In particular, 
in murine models of tissue injury, aged animals have a prolonged course of wound 
repair, associated with delays in re-epithelialization, neovascularization and restoration 
of the extracellular matrix (63). Following excisional wound injury, macrophage 
accumulation was elevated 56% at day 1 in aged mice as compared to young, and this 
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correlated with increased MCP-1 production (50). In macrophages isolated from 
subcutaneous implanted polyvinyl alcohol (PVA) sponges, aged mice demonstrated an 
approximate 40% decrease in phagocytosis as compared to young mice (50).  These 
delays in wound closure and diminished phagocytic ability of wound cells may 
contribute to the increased susceptibility to infection seen in elderly patients (119-121). 
Additionally, reduced macrophage phagocytosis may impair the ability to clear 
apoptotic keratinocytes or neutrophils from the wound bed, further delaying wound 
repair. Aprahamian et al. recently demonstrated that following ultraviolet B irradiation, 
aged mice demonstrated an elevated percentage of apoptotic keratinocytes compared 
young irradiate mice that was later correlated with reduced phagocytic capacity and 
apoptotic cell clearance in aged animals as compared to young (122).  
As macrophages act as to bridge the innate and adaptive immune responses, an 
interesting study by Agius et al. recently demonstrated  that cutaneous delayed-type 
hypersensitivity responses to bacterial, fungal or viral antigens by CD4
+
memory T cells 
is significantly decreased in older subjects (123). The defective T cell 
immunosurveillance was attributed to diminished production of TNF-α by cutaneous 
macrophages, resulting in reduced endothelial activation and a subsequent decrease in T 
cell recruitment to the aging skin. This study emphasize how a defect in the 
macrophage population with advanced age not only impairs the innate arm of the 
immune system, but can compromise the pathogen-specific adaptive immune response 
and result in a poor prognosis following injury and infection. Together, these findings 
may provide the foundation for improving our understanding of poor clinical outcomes 
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following tissue injury and infection with aging, and may lead to design of therapeutic 
interventions to enhance macrophage function and accelerate wound closure.  
 
Tumor Immunity 
Deficits in macrophage function also directly contribute to the increased 
incidence of neoplastic growth and metastasis in elderly patients.  In tumor 
immunology, recruitment of tumor associated macrophages (TAMs) results in the 
release of growth factors, proteases and inflammatory mediators, promoting 
vascularization of tumor tissue and metastasis (124). Infiltration of tumors by TAMs is 
associated with a poor prognosis (124), and age-related differences in TAM effector 
functions within tumors have been identified (125). In a B16 intraocular tumor model, 
aged mice exhibit increased infiltration of M2-polarized macrophages in contrast to 
young mice. These macrophages had elevated expression of pro-angiogenic VEGF and 
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 (TIE-2) (125). 
Depletion of macrophages by subconjunctival injections of clodronate-containing 
liposomes reduced tumor growth in 86% of mice compared to only a 10% reduction in 
young animals. Interestingly, the M2 macrophages in tumors from aged mice shared 
some phenotypic characteristics of myeloid-derived suppressor cells from the 
monocytic lineage, namely Ly6-C (125) and were also subject to depletion by the 
methods used above. In addition to TAM recruitment, macrophages from aged rodents 
have elevated cycloxygenase activity and prostaglandin E2 synthesis, mediators that 
have been recently implicated in tumorigenesis (93, 126). Further work to better 
characterize TAMs with aging and cancer subtypes may aid in development of targeted 
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cancer treatments for patients with poor prognoses due to TAM infiltration and 
subsequent neovascularization and metastasis.  
Age-related differences in macrophage function described above highlight how 
alterations in macrophage phenotype and function can facilitate development of 
infection, delays in tissue repair and impairment of tumor regression. Utilizing targeted 
rodent models to increase our understanding of how macrophages can contribute to 
specific pathological conditions may position us to better understand disease states at 
the bedside.  
 
Summary of Aging and the Innate Immune System 
Age-associated impairment in the various components of the immune system has 
been extensively studied. However, it is evident from the recent studies reported herein 
that some aspects of innate immunity require more investigation than others (e.g. AMPs). 
Tackling immunosenescence as it affects the innate arms of the immune system is a 
logical step forward as efficient antigen presentation and co-stimulation by macrophages 
and dendritic cells may promote a ‘normal’ humoral and cell-mediated immune response 
in aged individuals. Moreover, future aging research should focus on the key signaling 
molecules modulating the various signaling pathways involved in phagocyte and antigen 
presenting cell (APC) effector responses as well as cross-talk between these pathways. 
Furthermore, studying the intrinsic defects of a cell without the interference of the aged 
microenvironment is as crucial as focusing on the overall aged phenotype. Tailored and 
complementary in vitro and in vivo studies on the complex physiological interactions 
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between innate immune cells and tissue-specific environments can hold a promising 
future for aging research.  
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Innate Immune Cells as Regulators of Wound Healing 
Cutaneous wound healing is a dynamic process requiring coordination of immune 
cell infiltration, keratinocyte proliferation, angiogenesis, extracellular matrix deposition 
and collagen remodeling to ensure adequate wound closure (127-129). Proper regulation 
of this physiologic response to injury by crosstalk between various cell types and soluble 
factors facilitates restoration of the epidermal and dermal barrier with minimal scar 
formation (127, 130, 131). Multiple pathologic conditions, hormone status and advanced 
age are known to perturb efficient cutaneous repair by impacting one of the three 
interdependent phases of wound healing: the early inflammatory phase, proliferative 
phase or late remodeling phase (Figure 4) (127, 128, 131, 132). Innate immune cells are 
critical during these stages of wound repair, as changes in innate immune cell function 
have been shown to significantly augment normal wound healing, leading to poor wound 
closure or hypertrophic scar formation. Understanding the contribution of the innate 
immune response to wound repair and dermal restoration is instrumental in the rational 
development of clinical therapeutics that will enhance wound closure, decrease 
associated morbidities and reduce critical care costs. 
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Figure 4. Phase of cutaneous wound healing. Inflammatory phase: Immediately 
following tissue injury, platelets, local immune cells and keratinocytes release soluble 
mediators such as AMPs and pro-inflammatory cytokines/chemokines to help kill 
invading pathogens and recruit innate leukocytes. Then, neutrophil infiltration occurs as 
early as 6 hours and peaks between 18-24 hours in aseptic wound models. Macrophages 
are then recruited to help in pathogen and debris clearance, as well as mediating 
transition to the Proliferative phase. This phase is marked by angiogenesis, re-
epithelialization and collagen deposition. Lastly, wounds undergo a long Remodeling 
phase. Here, the initial collagen is crosslinked and remodeled in order to increase the 
tensile strength of the wound.  
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Antimicrobial Peptides as Early Mediators of Wound Healing 
 Integral to the host defense response at epithelial surfaces, AMPs serve to directly 
inhibit bacterial growth and help initiate recruitment of innate leukocytes (17, 133). As 
small amphipathic molecules, AMPs mediate bactericidal activity by integration and 
disruption of microbial membranes. Within the skin, several classes of AMPs, including 
cathelicidins (LL37/CRAMP) and -defensins, have been identified to be important in 
response to both infection and injury (13, 134). Human -defensin (hBD1) is 
constitutively expressed by keratinocytes, where as hBD-2/mBD-3 and hBD3/mBD14 are 
predominately upregulated following inflammation, tissue injury or infection (13-15). 
Namely, hBD2-4 have been shown to induce keratinocyte pro-inflammatory cytokine and 
chemokine secretion as well as enhancing keratinocyte migration and proliferation (135).  
In settings of non-healing wounds, such as diabetic foot ulcers, expression of 
activated human cathelicidin, LL37, was reduced compared to tissue from healthy donor 
skin (136). In parallel to this, murine studies in CRAMP
-/-
 mice report delayed wound 
healing. On the contrary, levels of hBD1-4 were elevated in tissue samples from non-
healing and diabetic foot ulcers (136, 137). Interestingly, in a porcine model of S. aureus 
excisional wound infection, treatment with human hBD3 enhanced bacterial clearance 
and wound re-epithelialization as compared to controls (138). Together, these data 
suggest that alterations in AMP expression or function may contribute to aberrant healing 
in pathologic settings, and reconstitution of functional AMPs could provide therapeutic 
options for chronic, non-healing wounds. 
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Controversial Role of Neutrophils in Wound Repair 
Neutrophils are typically described as the first class of infiltrating innate immune 
cells at the site of injury, helping to control potential infection by phagocytosis of foreign 
pathogens and removal of contaminating debris. Despite this necessary function, 
excessive release of enzymes by neutrophils, such as elastase, can be damaging to 
surrounding tissue, delaying rates of healing and increasing the risk of scar formation (65, 
130, 139, 140). For these reasons, the need for neutrophil infiltration following injury is 
heavily debated. In support of neutrophil-dependent wound healing, mice lacking the 
CXCR2 receptor responsible for neutrophil chemotaxis have an expected impairment in 
neutrophil recruitment to the site of injury (141).  Interestingly, this was accompanied by 
decreased re-epithelialization and angiogenesis (141). Despite insufficient neutrophil 
recruitment, monocyte and macrophage infiltration was actually enhanced in CXCR2 
deficient mice (141), suggesting that loss of the neutrophil population may alter the 
important, yet ill-defined, cross-talk between these two cell subsets in the context of 
wound healing. Moreover, aging studies support the necessity for neutrophil infiltration 
for efficient wound closure.  In these studies, neutrophil depletion further impairs rates of 
wound closure in aged mice (49). Additionally, topical application of isolated peritoneal 
neutrophils following injury or intravenous injection of G-CSF to mobilize neutrophils to 
the peripheral pool prior to wounding, enhanced rates of wound closure to that seen in 
young mice (49). These data imply that topical or systemic G-CSF treatment may provide 
a potential therapeutic avenue for neutropenic or immunocompromised individuals, such 
as cancer patients or the elderly, who may not be able to recruit adequate numbers of 
neutrophils to site of cutaneous injury and infection.  
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On the other hand, studies in young mice report a very divergent finding 
regarding neutrophil necessity in cutaneous repair. In vivo neutrophil depletion in young 
mice with rabbit anti-mouse sera prior to injury resulted in increased re-epithelialization 
out to day 3 post injury with no significant difference in macrophage infiltration (140). 
The evidence provided by Dovi et al. is supported by earlier findings that conclude 
neutrophils are either dispensable in cutaneous repair (142) or that their excessive 
presence is detrimental to the healing process (143). In the later study, impaired healing 
in a murine model of diabetes was associated with prolonged expression of MIP-2 and a 
concomitant extended infiltration of neutrophils at the site of injury (143). Also arguing 
against a positive effect of neutrophil recruitment to sites of aseptic injury are fetal 
wound healing models. Fetal wound healing is characterized by a pronounced decrease in 
inflammatory mediators and neutrophil recruitment at injury sites, minimal, if any scar 
formation, and swifter rates of wound closure (130, 131). While these data suggest that 
neutrophils may either be unnecessary or detrimental to prototypic wound repair, the 
aging studies provide an interesting point of contention. The differences observed in fetal, 
young and aged mice may actually highlight an aging difference reflective of the 
immunosenescent phenotype of the elderly, suggesting that modulation of wound closure 
by neutrophils may be required in the elderly yet detrimental in utero and in younger 
patients. While the current data are somewhat inconclusive regarding the positive and 
negative contribution of neutrophils to efficient wound repair, similar to many 
physiologic processes, it is highly likely that maintenance of a delicate balance is ideal 
for satisfactory wound repair. 
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Macrophages as Critical Mediators of Wound Healing 
There is a general acceptance that macrophages are instrumental in prototypic 
wound healing, being involved predominately in the inflammatory and proliferative 
phases of wound repair. Their crucial role is highlighted as impaired macrophage 
function or alterations in macrophage infiltration kinetics and duration are associated 
with a prolonged inflammatory response, inadequate wound closure and poor restoration 
of normal cutaneous architecture (127, 144-148). The critical function of macrophages is 
emphasized by studies utilizing selective depletion of the macrophage population 
immediately prior to injury (144). In these studies, macrophage ablation was associated 
with increased TNF- production and delayed re-epithelialization at 5 days post injury. 
These mice also exhibited decreased angiogenesis, as noted by diminished CD31
+
 
staining and reduced VEGF production, as well as impaired collagen production and 
decreased transforming growth factor – (TGF- production, implying that macrophages 
help modulate the wound inflammatory milieu and progression into the proliferative 
phase of wound healing (144). 
In addition to evidence supporting an absolute requirement for macrophages in 
efficient repair, reports suggest that macrophage phenotype plays a significant role in the 
modulation of the response to cutaneous injury (118, 145, 149). Following injury, 
peripheral blood monocytes extravasate to the wound site, undergoing differentiation into 
wound macrophages (79, 118). While initially thought of as alternatively activated, or 
M2-polarized, macrophages, emerging evidence supports that the first macrophages 
entering the wound site display a pro-inflammatory phenotype, marked by TNF- and 
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IL-6 production (118). As the inflammatory phase progresses, wound macrophages 
increase production of TGF- and express typical markers of alternative activation, 
including arginase1 and Ym1 (118). Interestingly, prolonged expression of classical 
markers of activation in wound macrophages is tied to failure of efficient wound 
resolution (145), implying that timely transition to an M2 phenotype is required for a 
competent physiologic response to cutaneous injury. Based on evidence that M2 
macrophages enhance wound repair, recent studies have utilized mesenchymal stem cells 
(MSC) to drive M2 polarization (149). Zhang et al. found that co-culture of gingiva-
derived MSCs could effectively home to sites of cutaneous injury, induce an M2 
phenotype and remarkably accelerate wound closure (149). While studies exploring the 
therapeutic potential of stem cells in human and animal models of cutaneous injury have 
consistently provided evidence that MSCs promote wound repair (reviewed in (150)), this 
is one of the first reports to postulate a mechanism by which MSCs directly interact with 
wound immune cells to enhance closure.  
Stem cell therapeutic interventions which augment macrophage function may be 
of particular interest in several patient populations, such as the elderly and diabetics (50, 
64, 119, 145, 151, 152). These patients are often plagued by prolonged rates of wound 
closure that are attributable to impaired macrophage function (50, 143, 145, 147). Wound 
macrophages in diabetic models exhibit decreased phagocytic function and heightened 
pro-inflammatory cytokine production (147), which may impair resolution and elevate 
the risk of infectious complications in a clinical setting. This impaired phagocytic 
capability was specifically characterized as defective macrophage efferocytosis (147), or 
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phagocytosis of apoptotic cells (153, 154). Increased apoptotic cell content in wounds 
from diabetic mice was associated with an overall delay in wound closure. Culture of 
isolated wound macrophages from diabetic mice with apoptotic thymocytes demonstrated 
a reduced ability clear dead cells (147). In line with this study, diabetic murine models of 
excisional skin injury or skin flap cutaneous injury demonstrated increased levels of 
MCP-1 in cutaneous wounds (143, 145). Heightened production of this chemokine 
correlated with enhanced macrophage infiltration and delayed wound closure (143) or 
reintegration of the injured flap (145). These data parallel studies in aging mouse models, 
in which impaired cutaneous wound closure in aged mice is associated with elevated 
MCP-1, increased macrophage infiltration and the prolonged presence of macrophages at 
the site of injury (50). Taken together, these data highlight the absolute necessity for 
intact macrophage function to effectively modulate the inflammatory and temporal 
response to wound injury. Perhaps treatment of clinically compromised wounds with 
MSC could not only aid in transition to the anti-inflammatory phenotype seen in both 
diabetics and the elderly, but rescue defective efferocytosis and phagocytosis to further 
aid in wound repair. As the knowledge of macrophage involvement in wound repair 
advances and evolves, this particular innate immune cell subset is likely to emerge as a 
key candidate for targeted intervention and treatment in non-healing, chronic wounds in 
at risk patient populations. 
 
Langerhan’s and Mast Cells in Cutaneous Wound Healing 
 Two additional innate leukocytes have been shown to have a hand in modulation 
of wound resolution, Langerhan’s cells (LC) and mast cells (MC). LCs, resident dendritic 
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cells of the epidermis, have been shown to have differential responses to two types of 
non-healing cutaneous ulcers: venous leg ulcers and diabetic foot ulcers (137). In patients 
with venous leg ulcers there was a decreased accumulation of CD1a
+
 LC at the site of 
injury as compared to aged matched controls. Conversusly, there was a marked increase 
in CD1a
+
 LC in patients with diabetic foot ulcers in comparison to controls. The authors 
attributed this difference to increased expression GM-CSF in keratinocytes present in 
diabetic foot ulcers (137). In an alternate study, enhanced LC accumulation was actually 
tied to excessive scar formation, as opposed to chronic wounds (155). Niessen et al. 
found that the number of LC in the epidermis was elevated in hypertrophic scars at 3 
months after surgery, though no difference was noted at 12 months (155). Clearly these 
studies outline that LC aid in regulation of wound repair, but their precise functional 
contributions are yet to be delineated.  
Mast cells, another epidermal resident leukocyte with known functions in 
autoimmune and inflammatory pathology, have been postulated to play a role in 
cutaneous wound healing (156-158). Studies utilizing MC-deficient mice have found that 
absence of MC delays wound closure and results in dysregulation of the inflammatory 
stage of wound healing through impaired neutrophil recruitment (157, 158). Weller et al. 
extended these findings by examining the role of MC histamine release as a potential 
mediator of the impaired wound closure seen in MC-deficient mice. These studies found 
that blockade of histamine 1 receptors impaired wound closure, and suggested that 
histamine release by activated MC may mediate the positive effect of MC on cutaneous 
healing (157). As histamine, a potent vasodilator, is common place in clinical practice, 
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topical application may serve as yet another targeted therapeutic to enhance wound 
closure and improve clinical outcomes following tissue injury. 
 
Summary of Innate Immune Cells as Mediators of Wound Healing 
 The physiologic response to cutaneous injury is undoubtedly a complex, highly 
regulated process. Likewise, the contribution of innate immune leukocytes and 
lymphocytes to this efficient wound repair process is multifaceted. As these cells are 
some of the earliest responders and mediators of the local response to cutaneous injury, 
they serve as ideal targets for modulation of the wound repair process. Early intervention 
in at risk patient populations with novel therapeutic strategies derived from our 
understanding of the innate mediators of tissue injury can potentially decrease the 
incidence and prevalence of chronic, non-healing wounds, reduce infectious 
complications and ameliorate associated health care costs. 
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Overall Significance: 
Age-Associated Alterations in Innate Immune Function and Wound Repair 
Increased human life expectancy over the last century has resulted in growth of the aging 
population; however, the prevalence of disease and associated morbidities among the 
elderly has also increased (1). Older patients are more susceptible to post-surgical 
infections and subsequent problematic wound closure with costly prolonged hospital 
stays (121, 159). In addition, these patients suffer from chronic wound states that offer 
persistent sites for infection by foreign pathogens (119, 151), potentially propagating 
infectious spread in long-term care settings. By determining how aging impairs innate 
immune cell function, novel therapeutic approaches that aid in resolution of wound 
infection may be realized, resulting in improved post-surgical outcomes, diminished rates 
of chronic wounds and a clinically significant reduction in morbidity and mortality in the 
elderly. 
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CHAPTER 3 
REDUCED NEUTROPHIL CHEMOTAXIS AND INFILTRATION CONTRIBUTES 
TO DELAYED RESOLUTION OF CUTANEOUS WOUND INFECTION WITH 
ADVANCED AGED 
 
Abstract 
 
Advanced age is associated with alterations in innate and adaptive immune responses, 
which contribute to an increased risk of infection in elderly patients. Coupled with this 
immune dysfunction, elderly patients have elevated rates of wound dehiscence, chronic 
wounds and wound infection, suggesting that aging impairs wound healing. To evaluate 
how advanced age alters the host immune response to cutaneous wound infection, we 
developed a murine model of cutaneous S. aureus wound infection in young (3-4 month) 
and aged (18-20 month) BALB/c mice. Aged mice exhibit increased bacterial 
colonization and delayed wound closure over time compared to young mice. These 
differences were not attributed to alterations in wound neutrophil or macrophage TLR2 or 
FcRIII expression, or age-related changes in phagocytic potential and bactericidal 
activity. However, reduced neutrophil and macrophage recruitment was observed in aged 
mice relative to young mice despite elevated KC, MIP-2 and MCP-1 chemokine levels at 
the wound site. In response to a subcutaneous injection of KC, aged mice recruited fewer 
neutrophils at increasing doses of KC compared to young mice, suggesting age impairs in 
vivo neutrophil chemotaxis to cutaneous tissue. These age-mediated defects in early 
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neutrophil recruitment may alter the dynamics of the inflammatory phase of wound 
healing, impacting macrophage recruitment, bacterial clearance and wound closure.  
Introduction 
An estimated 25 billion dollars in US health care expenditure is spent on care of 
chronic, non-healing wounds (151). One patient sub-population, the elderly, account for a 
major portion of patients afflicted by chronic and infected wounds (119, 151, 159). Aging 
is associated with a decline in immune function which can elevate rates of wound 
infection and delay wound closure in these patients (64, 160, 161). Moreover, advanced 
age is associated with a general decline in innate and adaptive immune function which 
contributes to an increased susceptibility to opportunistic bacterial and viral infections in 
the elderly (6, 159, 162, 163). Underlying this elevated susceptibility to infection are 
deficits in host recognition, phagocytosis, migration and activation of a pathogen-specific 
adaptive immune response (3, 45, 83, 164). In addition to the immunosenescence that 
accompanies aging, advanced age is also marked by heightened levels of circulating pro-
inflammatory mediators in the absence of an inciting stimulus, a state referred to as 
“inflamm-aging (56, 165).” Together, these phenomena are thought to contribute to poor 
outcomes following infection or trauma in clinical and animal models of aging (47, 48, 
89, 159, 166, 167).  
Alongside playing a critical role in eradication of foreign pathogens, the innate 
immune response is also crucial to tissue repair, another physiologic response 
compromised by aging. Cutaneous wound repair is a complex process, marked by 
immune cell infiltration and inflammation, fibroblast and keratinocyte proliferation, 
angiogenesis, and remodeling of the extracellular matrix to ensure restoration of the 
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normal skin barrier (118, 139, 160, 168, 169). Natural and succinct progression through 
these interdependent stages of wound healing is required to ensure rapid and adequate 
repair of epidermal and dermal architecture. Clinical observations reveal that elderly 
patients have an impaired response to cutaneous injury, resulting in elevated rates of 
wound dehiscence and subsequent chronic wounds (121, 151). Non-healing wounds in 
this patient population have an increased risk of infectious complications. This risk is 
associated with higher morbidity and mortality, and infectious spread in long-term care 
facilities (120). Moreover, older patients are more susceptible to post-surgical infections 
and subsequent problematic wound closure with costly prolonged hospital stays (121, 
159). 
Laboratory studies using murine models of cutaneous injury have substantiated 
the aforementioned clinical findings as advanced age has been shown to alter the 
dynamics of all stages of the wound repair process (49, 50, 63, 170). Evidence suggests 
age-associated differences in the magnitude and duration of neutrophil and macrophage 
infiltration into the wound bed during the inflammatory phase of wound healing (49, 50). 
These phagocytes are instrumental in limiting infectious spread and regulation of the 
temporal progression through the early phases of wound closure (118, 171, 172). Despite 
compromised immune function and increased rates of infectious wound complications in 
the elderly, the impact of advanced age on the host immune response to cutaneous wound 
infection has been neglected. S. aureus is a common dermatopathogen that accounts for 
at least 75% of skin and soft tissue infections and 30% of surgical-site infections, with a 
dramatic increase in S. aureus-associated surgical site infections to 50% in patients over 
65 (159, 173, 174).  We developed a cutaneous excisional S. aureus wound infection 
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model in young (3-4 month) and aged (18-20 month) BALB/c mice. In the setting of 
wound infection, we are the first to demonstrate that advanced age is associated with 
heightened bacterial colonization and delayed wound closure due to reduced innate 
immune cell recruitment.  
 
Materials and Methods 
Animal Model 
3-4 month old (young) and 18-20 month old (aged) BALB/c mice (Charles River/NIA, 
Kingston Facility, Stony Ridge, NY) were utilized to determine age-dependent 
differences in response to cutaneous wound injury and infection (Figure 5). All animal 
studies were approved and performed with strict accordance to the regulations established 
by the Loyola University Chicago Animal Care and Use Committee. Following 
acclimation at Loyola’s Animal Care Facility, young and aged mice were subjected to 
dorsal excisional cutaneous injury as previously described (175). Briefly, mice were 
administered intraperitoneal (i.p.) 100 mg/kg ketamine and 10 mg/kg xylazine followed 
by i.p. saline to ensure systemic distribution of the anesthetic. Once the mice no longer 
responded to firm pressure applied to their hind limb, their dorsum’s were shaved and 
cleansed with ethanol pads. Mice were then subjected to 6 dorsal full-thickness (skin and 
panniculus carnosa) cutaneous wounds with a 3 mm dermal punch biopsy (Acuderm, Ft. 
Lauderdale, FL). Immediately after injury, mice received ~10
3
 colony forming units 
(CFU)/10uL of S. aureus to each wound and were returned to their cages on heating pads. 
A low inoculum of bacteria was chosen to prevent sepsis which is known to negatively 
impact wound healing (176). S. aureus Newman strain was grown overnight in tryptic 
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soy broth (TSB) at 37
o
C under constant agitation. The next day, 1 mL of S. aureus in 
TSB was resuspended in 2mL fresh TSB and incubated at 37
o
C for 2 hours to ensure 
mid-logarithmic growth at the time of application to cutaneous wounds. Bacterial 
concentration (CFU/mL) was determined by absorbance at 600 nm and the final 
inoculum confirmed by back-plating on mannitol salt agar (MSA; BD Diagnostics, 
Sparks, MD). 
Mice were sacrificed at days 1, 3, 7 and 10 after injury and infection. The pelt was 
removed and photographed to measure wound size as described below. A larger 5 mm 
punch biopsy was used to remove the 3 mm wounds. Wounds were examined for 
bacterial colonization, ex vivo phagocytosis, flow cytometric analysis of wound immune 
infiltrate and cytokine and chemokine analysis as detailed below. Blood was obtained via 
cardiac puncture for flow cytometric analysis, as well as the bactericidal assay.  
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Figure 5. Model of S. aureus cutaneous wound infection in young and aged mice. 
Young (3-4 month) and aged (18-20 month) BALB/c mice were anesthetized and their 
dorsum shaved. Mice then received 6, 3 mm dorsal punch wound followed by ~10
3
 CFU 
of S. aureus per wound. Mice were sacrificed at days 1, 3, 7 and 10. Wounds were 
assessed for bacterial colonization, wound size, inflammatory cell infiltrate, cytokines, 
chemokines, phagocytosis and AMPs. The peripheral blood was harvested for evaluation 
by flow cytometry. 
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Bacterial Colonization 
Skin, spleen and kidney were each homogenized in 1 mL sterile phosphate buffered 
saline (PBS) and 10-fold serial dilutions to 10
6
 were plated on MSA plates (BD 
Diagnostics, Sparks, MD). Heparinized whole blood was directly plated onto MSA 
plates. Plates were incubated at 37
o
C for 24-48 hours and colonies were counted to 
determine levels of bacterial colonization. Significant bacterial dissemination to spleen, 
kidney and blood was not observed (data not shown). 
 
Wound Size 
Wound size was evaluated by digital photography and image analysis as previously 
described (175). Briefly, at days 1, 3, 7 and 10 wounds were photographed with a Canon 
EOS SLR digital camera. Each pelt photographed at a fixed distance of 20 cm with a 
ruler placed within the frame of each photograph. Photoshop 7.0 (Adobe Systems Inc., 
San Jose, CA) was used to determine the number of pixels in the open wound area using 
the magic wand tool, with zoom at 100% and a tolerance setting of 60. Separate animals 
were sacrificed immediately following wound injury and wound size was determined to 
represent day 0. Wound areas at each time point were compared with day 0 wounds: 
(pixels at days1-10/pixels at day 0)
x
100 were used to determine the percent open wound 
area at each time point. 
 
Skin and Whole Blood Flow Cytometry 
Single cell suspensions of wound cells for flow cytometry were generated as 
previously described (177). At days 1-7 after injury and infection, animals were 
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euthanized, pelts removed and wounds excised using a 5 mm punch biopsy. Diced 
wounds were incubated overnight at 4
o
C in RPMI 1640 culture media containing 10% 
fetal bovine serum (FBS) (Hyclone, Logan, UT), 2 mM L-glutamine (Gibco, Grand 
Island, NY), 1% penicillin/streptomycin (Gibco, Grand Island, NY), 2 mg gentamycin 
sulfate (Mediatech Inc, Manassas, VA) and 0.3 mg dispase II (Roche Diagnostics, 
Indianapolis, IN). The next day, tissue pieces were removed and subjected to further 
enzymatic digestion with 1 mg collagenase from Clostridium histolyticum type 1A 
(Sigma-Aldrich, St. Louis, MO), 1.2 mg DNAse I from bovine pancreas Grade II (Roche 
Diagnostics, Indianapolis, IN), 1 mg hyaluronidase from bovine testes type 1-S (Sigma-
Aldrich, St. Louis, MO), in RPMI 1640 with 5% FBS, 2 mM L-glutamine (Gibco, Grand 
Island, NY), 1% penicillin/streptomycin (Gibco, Grand Island, NY), 2 mg gentamycin 
sulfate (Mediatech Inc, Manassas, VA) and magnesium chloride hexahydtrate for 2 hours 
at 37
o
C. After two hours, these solutions were combined and debris removed by filtration 
with a 70 m filter. Cells that remained adherent to the tissue culture plastic were treated 
with Accutase (eBioscience, San Diego, CA) for 5-8 minutes at 37
o
C followed by 
vigorous pipetting. Cells were washed and adjusted to 1x10
6
/mL. Cells were blocked for 
20 minutes with FcBlock (anti-CD16/CD32, eBioscience) and rat IgG (Jackson Immuno), 
and then stained with PE-Cy7-F4/80 (eBioscience), FITC-Gr-1 (eBioscience, San Diego, 
CA), APC-CD3 (eBioscience) or APC-TLR2 (eBioscience, San Diego, CA). Cells were 
washed twice and then resuspended in flow buffer (1% bovine serum albumin (BSA), 
0.1% sodium azide and 2mM EDTA in PBS). For blood analysis, heparinzed whole 
blood was collected and stained per the manufacture’s protocol (Leinco Technologies). 
Whole blood (100 L) was blocked for 20 minutes with FcBlock and rat IgG and then 
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stained with PE-Cy7-F4/80, FITC-Gr-1 and PE-CXCR2. Following staining, erythrocytes 
were lysed with 2 mL Easy Lyse Solution (Leinco Technologies) for 11.5 minutes. Lysis 
was terminated by addition of 2 mL ice cold Wash Buffer (Leinco Technologies). Cells 
were washed twice in flow buffer and resuspended in 500 L flow buffer. Both skin and 
blood samples were collected on the FACSCanto I and FACS LSR Fortessa (BD 
Bioscience, San Jose, CA) and data were analyzed by FlowJo Software (Tree Star Inc, 
Ashland, OR). Fluorescence minus one control staining and single color controls were 
used to determine positive staining.  
 
Phagocytosis and FcRIII Staining 
Following isolation, wound cells were subjected to pHrodo-S. aureus phagocytosis as 
previously described (177). Cells were resuspended to 1x10
6
 cells/mL in Phagocytosis 
Uptake Buffer (Hank’s balanced salt solution (HBSS; Gibco, Grand Island, NY), with 20 
mM HEPES, pH 7.4) per the manufacturer’s instructions (Invitrogen, Carlsbad, CA). 
pHrodo-S. aureus  BioParticles (Invitrogen, Carlsbad, CA) were reconstituted to 1 
mg/mL in Phagocytosis Uptake Buffer and then opsonized with rabbit polyclonal IgG 
antibodies (Invitrogen, Carlsbad, CA) for 1 hour at 37
o
C. Control tubes for each animal 
were placed on ice (4
o
C) and experimental tubes placed at 37
o
C for 15 minutes to allow 
for temperature equilibration. pHrodo-S. aureus was then added at a ratio of 30:1 bacteria 
particles to cell. Samples were incubated for 0-60 minutes at 4
o
C (control) or 37
o
C 
(experimental) after which phagocytosis was stopped by addition of 2 mL ice cold 
Phagocytosis Uptake Buffer and placement on ice. Cells were blocked with rat IgG and 
anti-FcRII (R&D Systems, Minneapolis, MN), to block FcRI and FcRII, respectively, 
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for 20 minutes at 4
o
C. Samples were then stained with PE-anti-FcRIII (R&D Systems, 
Minneapolis, MN) for 30 minutes followed PE-Cy7-anti-F4/80 and FITC-anti-Gr1 for 30 
minutes at 4
o
C (178). Cells were washed twice, resuspended in flow buffer, and 
phagocytosis and FcRIII expression on wound neutrophils and macrophages were 
examined by flow cytometry. Data were acquired on the FACSCanto1 (BD Bioscience, 
San Jose, CA) and analyzed by FlowJo Software (Tree Star Inc, Ashland, OR). 
 
Peripheral Blood Neutrophil Isolation and Bactericidal Assay 
Heparinized whole blood was collected from unmanipulated animals and neutrophils 
sorted on the FACSAria. Briefly, 500-700uL heparinized blood was lysed according to 
the manufacturer’s instructions (Leinco Technologies). Cells were washed twice and 
resuspended in flow buffer. Cells were sorted based on forward (FSC) and side (SSC) 
scatter. Cytospins and Diff Quick staining of sorted cells were used to confirm purity by 
morphology. Sorted cells were evaluated for bactericidal activity as previously described 
with some modifications (179). Neutrophils were seeded at 10
5
 cells onto poly-L-lysine 
coverslips for 1 hour at 37
o
C.  S. aureus Newman was grown overnight in TSB, 
resuspended to 10
6
 CFU/mL in TSB and opsonized with 5% normal mouse serum in 
HBSS for 30 minutes at 37
o
C. Coverslips with incubated with bacteria (10:1 ratio of 
bacteria: cells) in HBSS for 15 minutes under agitation to allow phagocytosis to occur. 
Phagocytosis was stopped by placing coverslips in ice cold HBSS and washing three 
times. One coverslip was then lysed with ice cold ddH20 for 5 minutes. Lysates and 10-
fold serial dilutions of lysates were plated on MSA plated for 24-48 hours to determine 
the amount of bacteria phagocytosed.  The remaining coverslips were placed in HBSS for 
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45 or 75 minutes at 37
o
C to allow bactericidal activity to occur. At either 45 or 75 
minutes, coverslips were lysed with ice cold ddH20. Lysates and 10-fold serial dilutions 
of lysates were plated on MSA and incubated at 37
o
C for 24-48 hours. Bacterial growth 
was determined by colony counts. Bactericidal activity (percent killing) was determined 
by:  (number of colonies remaining at either 45 or 75 minutes/number of colonies initially 
present after the phagocytosis phase)*100.  
 
Chemokine Analysis 
One wound was homogenized in 1mL BioRad Cell Lysis buffer (BioRad, Hercules, CA) 
supplemented with Factor 1, Factor 2 and PMSF per the manufacturer’s instructions 
(BioRad, Hercules, CA). Homogenates were sonicated at 30%, syringe-
and chemokines (KC, MIP-2 and MCP-1) were analyzed by ELISA (R&D Systems, 
Minneapolis, MN) (180). 
 
In Vivo Chemotaxis 
Young and aged mice were administered 100 mg/kg ketamine and 10 mg/kg xylazine 
followed by saline to ensure systemic distribution of the anesthetic. Once the mice no 
longer responded to firm pressure applied to their hind limb, their dorsum’s were shaved 
and cleansed with ethanol pads. In the dorsal subscapular midline, mice received 
subcutaneous (s.c.)  injections of  100 or 1000 pg of recombinant mouse KC in a volume 
of 50 L or saline vehicle (50 L). Mice were sacrificed 8 hours after injections. The 
injection site and surrounding tissue were excised with an 8 mm punch biopsy and 
subjected to digestion as outlined above (177). Neutrophil recruitment to the injection site 
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was evaluated by flow cytometry as described above. Data are expressed as fold change 
of baseline neutrophil recruitment after saline injections. 
 
Statistical analysis 
Data are shown as mean ± standard error of the mean (SEM) of each group. Data were 
analyzed by Student’s t test or one- way or two-way ANOVA with Tukey’s or Bonferroni 
post-hoc tests, respectively, where appropriate using GraphPad Prism 5 (GraphPad, La 
Jolla, CA). A value of p ≤0.05 was considered significant. 
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Results 
Bacterial colonization and wound closure is impaired with advanced age. 
To evaluate the impact of advanced age on the innate immune response following 
cutaneous injury and S. aureus infection, we developed a model of cutaneous wound 
infection in young and aged mice to evaluate bacterial colonization and wound size at 
days 1, 3, 7 and 10 after injury and infection (Figure 5). Bacterial colonization in wounds 
from aged mice were elevated over the time course examined as compared to young 
mice, with post-hoc significance observed at day 3 (Figure 6, p<0.05). Levels of wound 
bacterial burden were unaltered in aged animals at day 7 as compared to day 3, whereas 
gradual reduction in wound bacterial content was observed in young animals by day 7. 
Moreover, by day 10, wounds from young mice averaged 10
3
 CFU/mL, compared to 10
6
 
CFU/mL in aged animals.  
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Figure 6. Wound bacterial colonization at days 1 through 10 following cutaneous 
injury and S. aureus infection. Young BALB/c (3-4 months, black circles and solid 
line) and aged Balb/C (18-20 months, black squares and dotted line) received six, 3mm 
dorsal cutaneous wounds followed by ~10
3 
CFU S. aureus/wound. At days 1, 3, 7 and 10 
after injury and infection, mice were sacrificed and bacterial colonization was determined 
by growth on MSA plates. Data are shown on a log scale as mean ± SEM, *p<0.001 
compared to young at same time point by two-way ANOVA; N=8-20 per group at each 
time point.  
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In parallel to these studies, wound size was evaluated by digital photography and 
image analysis. Compared to young mice, wounds from aged mice had a larger percent 
open wound area remaining at days 3 and 7 following injury and infection (Figure 7, 
p<0.05), with incomplete closure at day 10. At day 3, wounds in aged animals remained 
~80% open as compared to ~66% in young mice (Figure 7B, p<0.05). By day, an ~ 2-
fold increase in percent open wound area was observed in aged mice as compared to 
young (Figure 7B, p<0.05). The persistent open wound bed at day 10 in aged animals 
(~11% versus ~0.9% in young mice) could result in subsequent infectious complications 
in aged mice. Together, these findings recapitulate clinical observations of increased 
infectious complications and delayed healing with advanced age. 
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Figure 7. Wound size at days 1 through 10 following cutaneous wound infection 
with S. aureus.  (A) Representative images of wound from young (top panel) and aged 
(bottom panel) mice are days 1, 3, 7, and 10 after injury and infection. (B) Wound size 
expressed as percent open wound area relative to time zero at days 1, 3, 7 and 10 after 
cutaneous wound infection in young (black circle and solid line) and aged (black squares 
and dotted line) mice. Data are shown as mean ± SEM, **p<0.01 and *p<0.05 compared 
to young at same time point by two-way ANOVA; N=7-15 per group.
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Host recognition is not altered following injury and infection 
Previous studies have reported decreased TLR expression in various innate 
immune cell subsets with advanced age (reviewed in (3, 161)). TLR-1, -2 and -6 play 
critical roles in early host recognition of Gram-positive pathogens, and loss of TLR2 or 
downstream mediators of TLR signaling, such as MyD88, results in increased 
susceptibility to S. aureus infection (98, 181-183). Given differences in bacterial 
colonization at day 3, we chose to evaluate TLR2 expression on resident tissue 
macrophages (F4/80
+
Gr-1
- 
cells from uninjured skin) as well as on infiltrating wound 
leukocytes  in aged mice relative to young (Figure 8). In aged mice, a reduction in the 
absolute number of TLR2
+
 resident tissue macrophages (Figure 8B, p<0.05) was 
observed compared to young mice. Following injury and infection, there were no age-
dependent changes in the frequency of TLR2
+
 infiltrating macrophages and neutrophils 
(Figure 8C-D). Moreover, aging did not alter the expression of TLR2 on infiltrating 
leukocytes after injury and infection (Table 1). The changes in number of TLR2
+
 resident 
tissue macrophages with age may increase susceptibility to infection; however, following 
injury and infection, TLR2 expression did not contribute to prolonged bacterial infection 
in aged animals.  
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Figure 8. Expression of TLR2 by cutaneous neutrophils and macrophages. The 
number of neutrophils or macrophages expressing TLR2 was examined by flow 
cytometry. (A) Gating strategy for TLR2
+
 resident and infiltrating leukocytes. Live cells 
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were gated on Gr-1 and F4/80; F4/80
-
Gr-1
+
 (neutrophils), F4/80
+
Gr-1
-
 (macrophages).  
Neutrophil and macrophage populations were then evaluated for TLR2 positivity (dotted 
black line). (B) Absolute number of TLR2
+
 macrophages in uninjured skin from young 
and aged mice, *p<0.02 by Student’s t-test, N=7 per group. (C) Frequency of TLR2+ 
wound macrophages at day 1 and day 3 in young (gray bars) and aged (white bars) mice. 
(D) Frequency of TLR2
+
 neutrophils at day 1 and day 3 in young and aged mice. Data are 
shown as mean + SEM; N=8-17 per group. Data are not significant.  
 
Table I. MFI of TLR2 by cutaneous neutrophils and macrophages. 
 
Macrophages 
(F4/80
+
/Gr-1
-
/TLR2
+
) 
Neutrophils 
(F4/80
-
/Gr-1
+
TLR2
+
) 
Uninjured Day 1 Day 3 Day 1 Day 3 
Young 518.7±22.2 678.3±48.1 
 
603.0±17.0 612.1±39.1 451.6±15.9 
Aged 586.3± 42.0 627.5±42.3 642.2±41.5 576.0±30.5 441.6±13.2 
 
No difference was observed in the MFI of TLR2 in macrophages isolated from uninjured 
skin, or in the MFI of TLR2 in neutrophils or macrophages isolated from infected 
wounds. No significant differences between young and aged at each time point were 
observed. Data are shown as mean ± SEM; N=7-11 per group. 
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Bacterial clearance is not affected by advanced age 
In addition to recognition of bacteria by the host immune system, neutrophils and 
macrophages that are recruited to the wound site are required to phagocytose and clear 
invading organisms. In particular, deficiencies in neutrophil and macrophage 
phagocytosis, as well as bactericidal potential, have been associated with reduced 
bacterial clearance as well as chronic or repeated infections (43, 46, 120, 184). A major 
phagocytic pathway in these cells is the FcR pathway (32). Interestingly, reduced 
expression of FcRIII (CD16) and phagocytosis have been observed in neutrophils from 
aged humans (46). Similar studies in macrophage populations suggest a reduced 
phagocytic potential with advanced age (185-187). Thus, we sought to determine if 
differences in phagocytosis and FcRIII expression may contribute to delayed resolution 
of bacterial clearance in our model. Initially, we examined FcRIII expression in 
peripheral blood neutrophils in our young and aged animals pre- and post-infection. In 
line with studies by Butcher et al., there was a reduction in the frequency of FcRIII+ 
neutrophils in aged mice following injury and infection (Figure 9)(46).  
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Figure 9. Expression of FcRIII by peripheral blood neutrophils after injury and 
infection. Peripheral blood cells were stained for FcRIII expression by flow cytometry. 
(A) Gating of FcRIII+ neutrophil population (F4/80-Gr-1+FcRIII+). (B) Percentage of 
peripheral blood neutrophils expressing FcRIII in young (gray bars) and aged (white 
bars) mice. Data are shown as mean + SEM, *p<0.05 by one-way ANOVA with Tukey’s 
t-test; N=3-4 per group. 
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Butcher et al. had documented that reduced FcRIII expression was associated with 
reduce phagocytic potential in neutrophils isolated from the periphery of elderly subjects 
(46). Interestingly, few studies have examined the impact of the wound 
microenvironment on phagocytic cell function in the setting of advanced age. Given these 
data, we examined the phagocytic potential and the expression of FcRIII pre- and post- 
phagocytosis in wound cells isolated from young and aged mice. Phagocytosis of 
pHrodo-S. aureus bioparticles by wound neutrophils were not different in young and 
aged mice (Figure 10A-B). Despite no observed changes in phagocytosis, there were 
fewer FcRIII+ neutrophils pre- and post- phagocytosis in aged animals and the MFI of 
FcRIII was diminished (Figure 10C-D, p<0.05).  
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Figure 10. Wound neutrophil phagocytosis of S. aureus and FcRIII expression. 
Wound leukocyte suspensions were allowed to phagocytose pHrodo-S. aureus particles 
for 0-60 minutes and then stained for FcRIII expression. Phagocytosis and FcRIII were 
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assayed by flow cytometry. (A) Representative histograms (shaded gray-4
o
C, control; 
black-37
o
C, 30 minutes; and black dotted-37
o
C, 60 minutes) of phagocytosis by wound 
neutrophils (F4/80
-
Gr-1
+
S. aureus
+
). (B) Percentage of wound neutrophils that 
phagocytosed pHrodo-S. aureus particles in young (gray bars) and aged (white bars) 
mice. Data are not significantly different. (C) Percentage of wound neutrophils 
expressing FcRIII in young and aged mice; *p<0.05 versus young control, ‡p<0.001 
versus young phagocytosis, §p<0.05 versus young and aged controls by one-way 
ANOVA. (D) MFI of FcRIII on wound neutrophils from young and aged mice; 
§p<0.001 versus young control, ‡p<0.001 versus young control and 
phagocytosis,*p<0.001 versus aged matched control by one-way ANOVA. Data are 
shown as mean + SEM; N=9-12 per group for phagocytosis assays and N=4-8 for FcRIII 
studies.  
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Similar to these findings, no age-dependent changes in phagocytosis by wound 
macrophages were observed (Figure 11A-B). In both young and aged mice, the 
frequency of FcRIIIhi macrophages was reduced post-phagocytosis as compared to cells 
from age-matched controls (Figure 11C, p<0.05). However, there were no age-dependent 
differences in the frequency of total FcRIII+  macrophages between young and aged 
mice pre- or post-phagocytosis (Figure 11C). Moreover, there was a reduction in the 
MFI of FcRIII in aged mice compared to young regardless of exposure to pHrodo-S. 
aureus (Figure 11D, p<0.05).  
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Figure 11. Wound macrophage phagocytosis of S. aureus and FcRIII expression. 
Wound leukocyte suspensions were allowed to phagocytose pHrodo-S. aureus particles 
for 0-60 minutes and then stained for FcRIII expression. Phagocytosis and FcRIII were 
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assayed by flow cytometry. (A) Representative histograms (shaded gray-4
o
C, control; 
black-37
o
C, 30 minutes; and black dotted-37
o
C, 60 minutes) of phagocytosis by wound 
macrophages (F4/80
+
Gr-1
-
S. aureus
+
). (B) Percentage of wound macrophages that 
phagocytosed pHrodo-S. aureus particles in young (gray bars) and aged (white bars) 
mice. Data are not significant. (C) Percentage of wound macrophages expressing FcRIII 
in young and aged mice; *p<0.05 versus young control, ‡p<0.01 versus aged control by 
one-way ANOVA. (D) MFI of FcRIII on wound macrophages from young and aged 
mice; ‡p<0.01 versus young control,*p<0.05 versus young phagocytosis, §p<0.05 versus 
aged control by one-way ANOVA. Data are shown as mean + SEM; N=9-12 per group 
for phagocytosis assays and N=4-8 for FcRIII studies. *p<0.05 versus young control, 
§p<0.05 versus young control and young phagocytosis, ‡p<0.05 versus age control. 
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Though age did not impact the phagocytic potential of isolated wound neutrophils or 
macrophages ex vivo, decreased FcR expression has been shown to play a role in 
bactericidal activity via Rac-2 mediated formation of the NADPH oxidase complex (32, 
42). To evaluate if the observed reduction in FcRIII impaired the ability of neutrophils 
to kill ingested organism, isolated peripheral blood neutrophils were subjected to a 
modified bactericidal assay (179). Neutrophils were allowed to phagocytose opsonized 
pHrodo-S. aureus for  15 minutes, and percent killing of ingested bacteria was evaluated 
at 45 and 75 minutes after the end of the phagocytosis phase. No age-related differences 
in bactericidal activity were observed at either time point (Figure 12).   
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Figure 12. Bactericidal activity of peripheral blood neutrophils. Peripheral blood 
neutrophils were sorted from whole blood based on FSC and SSC via the FACSAria (A). 
(B) Cytospin of the sorted neutrophil population. hours to determine the amount of 
bacteria phagocytosed.  Bactericidal activity (percent killing) was determined by:  
(number of colonies remaining at either 45 or 75 minutes/number of colonies initially 
present after the phagocytosis phase)*100. Bactericidal activity at 45 minutes (C) and 75 
minutes (D). Data are shown as a scatter plot with mean + SEM; N=5-6 per group. Data 
are not significantly different.   
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Peak leukocyte infiltration is attenuated in aged mice 
As differences in host recognition, phagocytosis and bactericidal activity did not 
seem to contribute to delayed resolution of bacterial wound infection in aged animals, we 
hypothesized that age impairs the recruitment of leukocytes to the infected wound bed.  
Previous studies have documented that advanced age can alter the inflammatory cell 
infiltrate in non-infected wounds of aged mice (49, 50); however, the impact of cutaneous 
infection on leukocyte recruitment with age has not been examined. Wound leukocyte 
recruitment was assayed by flow cytometry at days 1-10 after injury and infection 
(Figure 13). At day 1, a similar number of wound neutrophils and macrophages were 
observed in young and aged mice (Figure 13A-B). However, at day 3, there was a 
reduction in neutrophil and macrophage numbers isolated from wounds from aged mice. 
(Figure 13A-B, p<0.05). Numbers of wound neutrophils and macrophages were 
comparable in young and aged mice at day 7, despite persistent infection in aged animals. 
No difference in T cell recruitment was noted at any time point (Figure 13C). The delay 
in neutrophil and macrophage recruitment at day 3 in aged animals may impair early 
bacterial clearance while the inability to recruit elevated numbers of leukocytes in aged 
mice at later time points may contribute to the persistent infection observed in these 
animals. Moreover, this altered leukocyte recruitment may perturb wound healing 
kinetics, delaying transition from the inflammatory to the proliferative phase and 
ultimately impairing wound closure and restoration of the dermal matrix. 
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Figure 13. Time course of cutaneous leukocyte accumulation following injury and 
infection. Leukocyte infiltration to the wound and surrounding tissue area of young (gray 
bars) and aged (white bars) was assessed by flow cytometry at days 1 through 10 post 
cutaneous wound infection. (A) Gating strategy for wound neutrophils (F4/80
-
/Gr-1
+
), 
wound macrophages (F4/80
+
/Gr-1
-
) and wound T cells (CD3
+
) by flow cytometry. (B) 
Absolute number of wound neutrophils; *p<0.01 compared to young at same time point 
by two-way ANOVA. Data are shown as mean ± SEM; N=8-19 per group at days 1-7, 
N=3-6 at day 10. (C) Absolute number of wound macrophages. Data are shown as mean 
± SEM; N=8-19 per group at days 1-7, N=3-6 at day 10. (D) Absolute number of wound 
T cells. Data are shown as mean ± SEM; N=3-9 per group. Data are not significantly 
different by two-way ANOVA. 
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Enhanced chemokine secretion in wounds from aged animals 
Important to neutrophil and macrophage recruitment are the chemotatic stimuli 
generated following tissue injury by keratinocyte and resident tissue leukocytes (128, 
188). To determine if the decreased neutrophil and macrophage numbers were due to 
reduced chemoattractant production, we evaluated the wound chemokine milieu. 
Interestingly, at day 1 following injury and infection, wounds from aged mice had 
elevated levels of KC and MIP-2, potent neutrophil chemokines and the murine 
homologs of human IL-8 (Figure 14A-B, p<0.05). Furthermore, wounds from aged mice 
had increased levels of MCP-1, a chemokine that helps recruit and differentiate 
circulating monocytes (Figure 14C, p<0.05). However, these elevated levels of 
neutrophil and macrophage chemokines were associated with similar neutrophil and 
macrophage recruitment at day 1. At day 3, when neutrophil and macrophage numbers 
were significantly reduced in aged animals, levels of these three chemotatic mediators 
were similar in young and aged mice (Figure 14, p<0.05). These data suggest that aged 
mice may require a stronger chemotatic stimulus at the site of injury and infection to 
generate recruitment of a similar number of infiltrating leukocytes.  
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Figure 14. Neutro hil and macrophage chemokine levels in wound homogenates. 
Neutrophil d macrophage chemokine levels in wounds of young (black circles and 
solid line) and aged (black squares and dotted line) mice present at the site of wound 
infection were measured by ELISA. (A) KC, *p<0.0001 compared to young at same time 
point by two-way ANOVA. (B) Macrophage inflammatory protein-2 (MIP-2), *p<0.05 
compared to young at same time point by two-way ANOVA. (C) Macrophage 
chemoattractant protein-1 (MCP-1), *p<0.05 compared to young at same time point by 
two-way ANOVA. Data are shown as mean + SEM; N=8-22 per group (days 0-3) and 
N=3-6 per group (day 7).  
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Elevated CXCR2 expression in peripheral blood neutrophils of aged animals following 
injury 
KC and MIP-2 are ligands for the chemotatic receptor CXCR2 present on 
circulating neutrophils (189). Ligation of CXCR2 results in upregulation of selectins and 
adhesion molecules which allow neutrophils to roll, adhere and subsequently 
transmigrate across endothelial walls to reach the site of injury or infection (26, 28, 190, 
191). Considering a strong chemotatic stimulus was present at the wound site in aged 
animals, we examined the peripheral neutrophil pool to determine if age-dependent 
differences in CXCR2 expression could account for reduced leukocyte recruitment with 
age. Following injury and infection at days 1 and 3, the frequency of neutrophils in 
circulation was elevated in aged mice compared to young mice at both time points 
(Figure 15A-B, p<0.05). There was no difference in the frequency of CXCR2
+
 
neutrophils between young and aged mice prior to or following injury (Figure 15C). 
Following cutaneous wound infection, downregulation of CXCR2 expression was 
observed in mice of both age groups, however the MFI of CXCR2 on neutrophils from 
aged mice was significantly elevated (Figure 15D). This elevation persisted out to day 3, 
where CXCR2 expression remained increased in aged mice relative to young mice. These 
data suggest that mediators downstream of CXCR2 may contribute to decreased 
neutrophil recruitment to the wound site in aged animals. 
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Figure 15. Peripheral blood neutrophil frequency and chemokine receptor 
expression. Whole blood was analyzed by flow cytometry to determine the percentage of 
circulating neutrophils and expression of the chemotatic receptor CXCR2. (A) Gating 
strategy for neutrophils in whole blood by flow cytometry. (B) Percentage of circulating 
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neutrophils in peripheral blood in young (gray bars) and aged (white bars) mice. (C) 
Frequency of CXCR2
+
 neutrophils in peripheral blood. (D). Expression of CXCR2 on 
peripheral blood neutrophils. Data shown as mean + SEM, N=9-18, *p<0.05 and 
**p<0.001 versuss young at same time point by two-way ANOVA. 
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Aging impairs in vivo chemotaxis to dorsal cutaneous skin 
Reduced neutrophil accumulation in spite of increased CXCR2 expression 
coupled with a comparable chemotactic stimulus in aged mice as compared to young 
suggests that aging may contribute to a neutrophil migratory defect. Previously, our 
laboratory has demonstrated that peripheral blood neutrophils from aged animals 
demonstrate a basal hyperchemokinesis with a reduced directional migration toward a 
chemotatic stimulus in vitro (60). We extended these findings to determine if reduced 
neutrophil numbers in cutaneous infected wounds in aged animals may be due to a 
chemotatic deficiency in vivo. Following s.c. injection of 100 pg of KC, neutrophil 
recruitment to the dorsal skin in aged mice was reduced as compared to young (Figure 
16, p<0.05). To determine if this could be overcome by higher doses of a chemotactic 
agent, we evaluated neutrophil recruitment after injection of 1,000 pg of KC. At a ten-
fold higher dose, aged mice still had impaired neutrophil recruitment as compared to their 
younger counterparts given the same dose (Figure 16, p<0.05). However, neutrophil 
recruitment in aged mice at a dose of 1000 pg was similar to that observed in young mice 
at a dose of 100 pg. These findings parallel our results observed following cutaneous 
wound infection in aged mice, suggesting that a higher chemotatic stimulus may be 
required to mediate a similar chemotatic response with advanced aged. Together, these 
data suggest that reduced neutrophil recruitment to site of cutaneous wound infection 
may be due to impaired chemotaxis with advanced age, independent of the level of 
chemoattractant stimuli or CXCR2 expression. 
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Figure 16. In vivo neutrophil chemotaxis in response to KC. Young and aged mice 
were injected s.c. with increasing doses of KC (0, 100 and 1000 pg) and neutrophil 
recruitment to the skin was examined by flow cytometry. Data are shown as mean + 
SEM, N=3-6 per group, *p<0.05 versuss young at same time point by two-way ANOVA. 
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Summary 
We developed a murine model of S. aureus cutaneous wound infection that allows 
for assessment of age-dependent differences in the innate immune response. In aged 
animals, we observed elevated levels of bacteria in wounds at early time points with 
active infection to 10 day in aged animals. Our data is in concert will clinical and murine 
studies that demonstrate aging is associated with elevated rates of infection (121, 159, 
174, 192). Furthermore, we are the first to demonstrate that wound closure was delayed 
in aged animals as compared to young following S. aureus wound infection. Again, these 
studies are in-line with aging mouse studies that report decreased wound healing in 
aseptic wound models (49, 63).  
We evaluated several parameters of the innate immune response to determine 
what may be contributing to these age-associated differences in bacterial burden and 
wound healing. First, we examine TLR2, a PRR responsible for initiating immune 
responses to Gram-positive bacteria. While we observed a reduction in TLR2 expression 
in resident tissue macrophages from uninjured skin in aged mice, these age-related 
differences were not observed in infiltrating leukocytes at days 1 and 3 after injury and 
infection. These data suggest that diminished TLR2 levels in resident macrophages may 
play a role in heightened susceptibility to infection with age; however, alterations in 
TLR2 likely do not contribute to delayed resolution of wound infection in aged animals. 
While some groups have reported that aging negatively impacts a variety of TLRs (74), 
others demonstrate no impact of age on TLR expression in a variety of cell subsets (74, 
101, 192). These reports suggest that the effect of age on TLR expression or function 
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may be cell type or model dependent, and future work to clarify the impact of age on 
TLR function needs to be conducted in clinical relevant models.  
Another critical neutrophil and macrophage function is phagocytosis and killing 
of foreign pathogens. Previous studies have reported that aging negatively impacts 
neutrophil and macrophage phagocytosis (46, 50, 120, 185, 186), though few have 
evaluated the phagocytic potential of leukocytes following recruitment in response to 
tissue injury. In our model of wound infection, no age-dependent differences in wound 
neutrophil or macrophage phagocytosis were noted. Downstream of FcR activation, the 
small GTPase Rac2 plays an essential role in assembly and recruitment of the NADPH 
oxidase complex to the phagosome to mediate bactericidal activity (32, 42). Despite 
reduction of FcR levels in aged animals, no difference in bactericidal activity was 
observed. While other Fc receptors and phagocytic pathways were not examined, our data 
imply that age does not impair Fc-mediated phagocytosis in wound neutrophils or 
macrophages. 
Most appreciably, we observed delayed recruitment of neutrophils and 
macrophages to the site of wound infection in aged animals as compared to young. 
Alterations in infiltration of these cells can impact several facets of wound healing. For 
example, reduced phagocyte recruitment may impair bacterial clearance and promote 
infectious spread (193). Moreover, studies in aging models have suggested requirement 
for neutrophils in successful wound healing with advanced age (49). Increasing 
neutrophil numbers via G-CSF administration enhanced rates of wound closure in aged 
mice to those observed in young mice (49). In the context of an infected wound, the need 
for neutrophil infiltration becomes increasingly paramount as patients with reduced 
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neutrophil function or numbers are at a heightened risk for chronic and repeated 
infections with catalase-positive bacteria, like S. aureus (43, 184, 194). Thus, the 
decreased absolute numbers of neutrophils and macrophages in our model may not only 
contribute to bacterial colonization differences observed with age, but may also play a 
role in delayed wound resolution in aged animals. 
As mentioned previously, this weakened neutrophil response may impair 
resolution of wound infection in aged mice. Recently, we demonstrated that peripheral 
blood neutrophils from unmanipulated young and aged mice have a basal 
hyperchemokinesis but lack directional migration ex vivo (60). These studies extend these 
findings and show a reduced migratory response to in vivo, s.c. KC in aged mice relative 
to young. Interestingly, this impaired recruitment to cutaneous tissues was observed in 
spite of elevated CXCR2 expression on circulating neutrophils from aged animals. 
Together, these data indicate that signaling downstream of CXCR2 may be altered with 
age. Future work to determine the mechanism associated with impaired chemotaxis with 
age may translate into therapeutic modalities which can improve resolution of wound 
infection in aged animals.
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CHAPTER 4 
G-CSF ENHANCES RESOLUTION OF STAPHYLOCOCCUS AUREUS WOUND 
INFECTION IN AN AGE-DEPENDENT MANNER 
 
Abstract 
This study tested the hypothesis that heightened bacterial colonization and delayed 
wound closure in aged mice could be attenuated by G-CSF treatment. Previously, we 
reported that aged mice had elevated bacterial levels, protracted wound closure and 
reduced wound neutrophil accumulation following S. aureus wound infection relative to 
young mice. In aseptic wound models, G-CSF treatment improved wound closure in aged 
mice to rates observed in young mice. Given these data, our objective was to determine if 
G-CSF could restore age-associated differences in wound bacterial burden and closure 
and increase wound neutrophil recruitment. Young (3-4 month) and aged (18-20 month) 
BALB/c mice received three dorsal, subcutaneous injections of G-CSF (250 pg/50 
l/injection) or saline control (50 l/injection) 30 minutes after wound infection. Mice 
were sacrificed at days 3 and 7 post wound infection and bacterial colonization, wound 
size, wound leukocyte accumulation and peripheral blood were evaluated. At days 3 and 
7 after wound infection, bacterial colonization was significantly reduced in G-CSF-
treated aged mice to levels observed in saline-treated young animals. Wound size was 
reduced in G-CSF-treated aged animals, with no affect on wound size in G-CSF-treated 
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young mice. Local G-CSF treatment significantly enhanced neutrophil wound 
accumulation in aged mice at day 3 and 7, whereas there was no G-CSF-induced change 
in young mice. G-CSF treatment did not significantly impact macrophage or T cell 
infiltration at days 3 and 7 in young or aged mice. These data demonstrate that G-CSF 
enhances bacterial clearance and wound closure in an age-dependent manner. Moreover, 
G-CSF may be of therapeutic potential in the setting of post-operative wound infection or 
chronic, non-healing wounds in elderly patients. 
 
Introduction 
Chronic, non-healing wounds are estimated to account for over 25 billion dollars 
in US health care costs (151). The failure to effectively heal wounds is often compounded 
by co-morbidities, such as diabetes or obesity. Another major patient population afflicted 
with chronic wounds are the elderly (119, 151, 159). With advanced age, a decline in 
immune function elevates rates of wound infection and further impairs wound closure in 
these patients (64, 160, 161). In particular, S. aureus infection accounts for 30% of 
surgical site infections in healthy, non-aged patients (159). In the elderly, S. aureus 
infection jumps to 50%, suggesting a proclivity of this Gram-positive bacterium for the 
immunocompromised (159). This increased predilection for infectious complications 
raises additional public health concerns, such as prolonged hospital stays, risk for septic 
complications or infectious spread in long-term care accommodations. As we continue to 
see a precipitous rise in the aged population, the number of total patients affected by non-
healing wounds is expected to rise from the estimated 6.5 million (151). Moreover, 
despite investment in antibiotic development for multi-drug resistant bacterial strains, 
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these bacteria continually evolve to evade our treatment options (195). New therapeutic 
targets that harness the host immune system to help eradicate infection and promote 
efficient wound healing will be necessary to decrease the public health cost due to 
chronic wounds and wound infection (184). 
Despite the knowledge that aging impairs wound healing, little has been done to 
determine how the early innate immune response is altered with age in the setting of 
wound infection. Models of aging and wound healing have shown alteration in the innate 
immune response during the early inflammatory phased of wound healing, as well as 
perturbations in mediators of the proliferative and remodeling stages (50, 63, 196-199). 
To evaluate how age negatively impacts the innate immune response to cutaneous wound 
infection, we previously developed a model of cutaneous wound injury and S. aureus 
infection in young and aged BALB/c mice. In this model, aged mice had heightened 
levels of bacterial colonization and delayed wound closure as compared to young 
animals. These findings were associated with reduced neutrophil recruitment to the 
wound site, despite elevated chemokine levels and adequate peripheral blood neutrophil 
CXCR2 expression. Moreover, we saw diminished neutrophil chemotaxis to the skin 
following subcutaneous injections of the murine neutrophil chemoattractant KC.  Others 
have demonstrated that addition of G-CSF to their model of aseptic wound healing 
enhanced wound closure in aged animals (49), and that G-CSF can restore defects in age-
associated neutrophil chemotaxis (200). Herein, we are the first to demonstrate that local 
administration of G-CSF reduced bacterial colonization and enhanced wound closure in 
aged animals via increased neutrophil recruitment at early time points. These data suggest 
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that local G-CSF treatment may serve as a potential therapeutic intervention in elderly 
patients with wound infections. 
 
Materials and Methods 
Animal Model of Cutaneous Injury and Infection 
Young (3-4 month) and aged (18-20 month) BALB/c mice (Charles River/NIA, 
Kingston Facility, Stony Ridge, NY) were used to determine if local, subcutaneous (s.c.) 
G-CSF treatment could restore age-dependent differences to S. aureus wound infection 
(Figure 17). All animal studies were approved and performed with strict accordance to 
the regulations established by the Loyola University Chicago Animal Care and Use 
Committee. Following acclimation at Loyola’s Animal Care Facility, young and aged 
mice were subjected to dorsal excisional cutaneous injury as previously described (175). 
Briefly, mice were given 10 mg/kg xylazine and 100 mg/kg ketamine intraperitoneal 
(i.p.) followed by i.p. saline to ensure systemic distribution of the anesthetic. Dorsal skin 
of the mice was placed over a hockey puck, and mice were subjected to 3 sets of 2, 3 mm 
dermal punch wounds (Acuderm, Ft. Lauderdale, FL) for a total of 6 dorsal full-thickness 
cutaneous wounds. Immediately after injury, mice received ~10
3
 CFU of S. aureus/10 L 
of saline and were returned to their cages on heating pads. At 30 minutes after injury and 
infection, animals received three s.c. G-CSF injections (250 pg/50 l/injection; R&D 
Systems, Minneapolis, MN) or saline vehicle injections (50 l/injection) in the dorsal 
midline in between each set of wounds. As sepsis is known to negative impact wound 
healing, a low bacterial inoculum was used to limit the risk of systemic dissemination of 
bacteria (176). S. aureus Newman strain was grown overnight in TSB at 37
o
C under 
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constant agitation. The next day, 1 mL of the overnight culture was resuspended in 2mL 
fresh TSB and incubated at 37
o
C for 2 hours to ensure mid-logarithmic growth at the time 
of application to cutaneous wounds. Absorbance at 600 nm was used to determine the 
bacterial concentration (CFU/mL) and the final inoculum was confirmed by back-plating 
on MSA (BD Diagnostics, Sparks, MD). 
Mice were sacrificed at days 3 and 7 after injury and infection. The pelt was 
removed and photographed to measure wound size as described below. A larger 5 mm 
punch biopsy was used to remove the 3 mm wounds. Wounds were examined for 
bacterial colonization and flow cytometric analysis of wound immune infiltrate (Brubaker 
et. al 2012, manuscript submitted). Heparinized whole blood was obtained via cardiac 
puncture for flow cytometric analysis (Brubaker et. al 2012, manuscript submitted). 
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Aged: 18-20 months
Anesthetized
and shaved
3 and 7 days after injury and
infection mice were sacrificed
Bacterial  Colonization 
Wound Size
Inflammatory Cell Infiltrate
Peripheral Blood Profile
Wound + S. aureus 
(~103 CFU/wound)    
Saline Vehicle
(3, 50 L dorsal,
s.c. injections)     
G-CSF Treatment
(3, 250 ng/50Lsaline
dorsal, s.c. injections)
 
Figure 17. Model of S. aureus cutaneous wound infection +/- G-CSF treatment in 
young and aged mice. Young (3-4 month) and aged (18-20 month) BALB/c mice were 
anesthetized and their dorsum shaved. Mice then received 6, 3 mm dorsal punch wound 
followed by ~10
3
 CFU of S. aureus per wound. Saline or G-CSF was administered 30 
minutes after injury and infection. Mice were sacrificed at days 3 and 7. Wounds were 
assessed for bacterial colonization, wound size and inflammatory cell infiltrate. The 
peripheral blood was harvested for evaluation by flow cytometry. 
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Bacterial Colonization 
One skin wound was homogenized in 1 mL sterile PBS (Gibco, Grand Island, 
NY) and 10-fold serial dilutions to 10
6
 were plated on MSA plates (BD Diagnostics, 
Sparks, MD). Plates were incubated for 24-48 hours at 37
o
C and colonies were counted to 
determine levels of bacterial colonization (Brubaker et. al 2012, manuscript submitted).  
 
Wound Size 
Wound size was evaluated by digital photography and image analysis as 
previously described (175). At days 3 and 7 wounds were photographed with a Canon 
EOS SLR digital camera. Each pelt was placed flat on a hockey puck and photographed 
at a fixed distance of 20 cm with a ruler placed within the frame of each photograph. 
Photoshop 7.0 (Adobe Systems Inc., San Jose, CA) was used to determine the number of 
pixels in the open wound area using the magic wand tool, with a tolerance setting of 60 
and zoom at 100%. Separate animals were sacrificed immediately following wound 
injury and wound size was determined to represent day 0. Wound areas at each time point 
were compared with day 0 wounds: (pixels at days1-10/pixels at day 0)
x
100 were used to 
determine the percent open wound area at each time point. 
 
Skin Cell Isolation and Flow Cytometry 
Single cell suspensions of wound cells for flow cytometry were generated as 
previously described (177). At days 3 and 7 after injury and infection, animals were 
euthanized, pelts removed and wounds excised using a 5 mm punch biopsy. Two diced 
wounds were incubated overnight at 4
o
C in RPMI 1640 culture media (Gibco, Grand 
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Island, NY) containing 10% FBS (Hyclone, Logan, UT), 2 mM L-glutamine (Gibco, 
Grand Island, NY), 1% penicillin/streptomycin (Gibco, Grand Island, NY), 2 mg 
gentamycin sulfate (Mediatech Inc, Manassas, VA) and 0.3 mg dispase II (Roche 
Diagnostics, Indianapolis, IN). Tissue pieces were then removed and subjected to further 
enzymatic digestion with 1 mg collagenase from Clostridium histolyticum type 1A 
(Sigma-Aldrich, St. Louis, MO), 1.2 mg DNAse I from bovine pancreas Grade II (Roche 
Diagnostics, Indianapolis, IN), 1 mg hyaluronidase from bovine testes type 1-S (Sigma-
Aldrich, St. Louis, MO), in RPMI 1640 with 5% FBS, 2 mM L-glutamine, 1% 
penicillin/streptomycin, gentamycin and magnesium chloride hexahydtrate for 2 hours at 
37
o
C. After two hours, these solutions were combined and adherent cells were treated 
with Accutase (eBioscience, San Diego, CA) for 8 minutes at 37
o
C followed by vigorous 
pipetting. Single cells suspensions were filtered through at 70 m filter to remove debris. 
Cells were washed and adjusted to 1x10
6
/mL. Wound cells were blocked for 20 minutes 
with FcBlock (anti-CD16/CD32, eBioscience) and rat IgG (Jackson ImmunoResearch, 
West Grove, PA), and then stained with PE-Cy7-F4/80 (eBioscience, San Diego, CA), 
FITC-Gr-1 (eBioscience, San Diego, CA) and APC-CD3 (eBioscience, San Diego, CA). 
Cells were washed twice and then resuspended in flow buffer (1% BSA (Sigma-Aldrich, 
St. Louis, MO), 0.1% sodium azide and 2mM EDTA in PBS). Events were collected on 
the FACS LSR Fortessa (BD Biosciences, San Jose, CA) and data were analyzed by 
FlowJo Software (Tree Star Inc, Ashland, OR). Fluorescence minus one control staining 
and single color controls were used to determine positive staining. F4/80
+
Gr-1
-
 cells were 
considered macrophages, F4/80
-
Gr-1
+
 cells were considered neutrophils and CD3
+
 cells 
were considered T cells. 
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Blood Flow Cytometry 
Heparinized whole blood was collected and stained per the manufacture’s 
protocol (Leinco Technologies, St. Louis, MO). 100 L whole blood was blocked for 20 
minutes with FcBlock and rat IgG and then stained with PE-Cy7-F4/80, FITC-Gr-1 and 
PE-CXCR2 (R&D Systems, Minneapolis, MN). Erythrocytes were then lysed with 2 mL 
Easy Lyse Solution (Leinco Technologies, St. Louis, MO) for 11.5 minutes. Lysis was 
stopped by addition of 2 mL ice cold Wash Buffer (Leinco Technologies, St. Louis, MO) 
and placement on ice. Cells were washed twice and resuspended in 500 L flow buffer. 
Events were collected on the FACS LSR Fortessa (BD Biosciences, San Jose, CA) and 
data were analyzed by FlowJo Software (Tree Star Inc, Ashland, OR). Fluorescence 
minus one control staining and single color controls were used to determine positive 
staining. F4/80
-
Gr-1
+
 cells were considered peripheral blood neutrophils. 
 
Statistical analysis 
Data are shown as mean ± SEM of each group. Data were analyzed by Student’s t 
test or one-way ANOVA with Tukey’s post-hoc tests where appropriate using GraphPad 
Prism 5 (GraphPad, La Jolla, CA). A value of p ≤0.05 was considered significant.  
 
 
 
 
 
 
92 
Results 
Local G-CSF treatment improves resolution of bacterial infection and wound closure in 
aged mice 
 Previously, we demonstrated that aged mice exhibited elevated bacterial 
colonization following cutaneous S. aureus wound infection that correlated with reduced 
neutrophil recruitment (Brubaker et. al 2012, manuscript submitted). G-CSF has been 
shown to enhance neutrophil recruitment and improve wound closure in aged animals 
(49), as well as restore age-associated chemotatic defects (200). Thus, we chose to 
investigate if G-CSF could restore bacterial clearance in aged mice by enhancing wound 
leukocyte recruitment. Following G-CSF administration,  we saw a 75% decrease in 
bacterial colonization at day 3 in aged mice as compared to aged, saline control animals 
(Figure 18A, p<0.05). At day 3, G-CSF did not affect wound bacterial levels in young 
mice.  These differences in wound S. aureus colonization persisted out to day 7 with a 
97% reduction in bacterial growth in aged animals administered G-CSF compared to 
aged-saline control (Figure 18B, p<0.05). While a mild elevation in day 7 wound 
bacterial levels in G-CSF-treated young mice was observed, this difference was not 
statistically significant from young saline.  
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Figure 18. Local G-CSF treatment reduces bacterial colonization in aged mice. 
Young BALB/c (3-4 month, gray bars) and aged BALB/c (18-20 month, white bars) 
received six, 3 mm dorsal cutaneous wounds followed by ~10
3 
CFU S. aureus/wound. 30 
minutes after injury and infection, mice either received s.c. G-CSF injections (250 ng/50 
l/injection) or saline vehicle injections (50 l/injection). At days 3 (A) and 7 (B), mice 
were sacrificed and bacterial colonization was determined by growth on MSA plates. 
Data are shown as mean ± SEM, *p<0.05 compared to young saline and **p<0.01 
compared to aged saline by one-way ANOVA; N=7-14 per group.  
Day 3 
Day 7 
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In concert with these data, we observed that local injection of G-CSF enhanced wound 
closure in aged animals at day 3 compared to aged, saline controls (Figure 19A+B, 
p<0.05). At day 7, differences in wound size observed between saline treated young and 
aged mice was ameliorated following G-CSF treatment (Figure 19A+C, p<0.05). G-CSF 
treatment did not affect that rate of wound closure in young mice at day 3 or 7. 
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Figure 19. Treatment with G-CSF abrogates age-associated deficits in wound 
closure. (A) Representative images of wound from young (left panel) and aged (right 
panel) mice at days 3 (top panel) and 7 (bottom panel) after S. aureus wound infection 
with or without G-CSF treatment. Wound size expressed as percent open wound area 
relative to time zero at days 3 (B) and 7 (C) after cutaneous wound infection in young 
(gray bars) and aged (white bars) mice. Data are shown as mean ± SEM, *p<0.05 
compared to young saline, **p<0.01 compared to aged saline and ‡p<0.05 compared to 
young G-CSF by one-way ANOVA; N=7-14 per group. 
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Wound neutrophil recruitment in aged animals in enhanced by local G-CSF treatment 
 Given that G-CSF restored bacterial clearance and wound closure in aged mice, 
we sought to examine if this correlated with enhanced leukocyte recruitment to the 
wound bed (Figure 20A). At day 3 following injury and infection, saline-treated aged 
mice had reduced absolute numbers of neutrophil and macrophage accumulation 
compared to young, saline treated mice (Figure 20B+C, p<0.5). Treatment with G-CSF 
increased neutrophil numbers in aged mice in respect to aged, saline treated animals 
(Figure 20B, p<0.05) and neutrophil recruitment was no longer different from young 
mice. No differences in neutrophil accumulation in young mice administered saline or G-
CSF were observed. G-CSF treatment did not impact macrophage recruitment at day 3 in 
aged animals (Figure 20C). While a mild reduction in macrophage recruitment in young 
animals given G-CSF was observed, these differences were not significant. At day 7, G-
CSF treatment resulted in protracted neutrophil accumulation of wound in aged animals 
as compared to all other groups (Figure 20D). This prolonged neutrophil infiltration may 
contribute to the reduced bacterial colonization observed in aged animals. No difference 
between wound macrophage accumulation was observed in saline- or G-CSF-treated 
young and aged mice (Figure 20E). Wound T cell recruitment at day 3 and 7 was similar 
between young and aged mice, and these numbers were not significantly affected by 
treatment with G-CSF (Table II). 
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Figure 20. Neutrophil accumulation is enhanced in aged mice following G-CSF 
treatment. Leukocyte infiltration to the wound and surrounding tissue area was assessed 
by flow cytometry at days 3 and 7 following cutaneous wound infection and G-CSF 
treatment. (A) Gating strategy for wound neutrophils (F4/80
-
/Gr-1
+
), wound macrophages 
Day 3 
Day 7 Day 7 
Day 3 
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(F4/80
+
/Gr-1
-
) and wound T cells (CD3
+
) by flow cytometry. Absolute number of wound 
neutrophils and macrophages at day 3 (B+C, respectively) and day 7 (D+E, respectively). 
Data are shown as mean ± SEM, *p<0.05 compared to young saline, **p<0.01 compared 
to aged saline and ‡p<0.05 compared to young G-CSF by one-way ANOVA; N=7-14 per 
group. 
 
Table II. Wound T cell numbers in saline and G-CSF treated mice. 
Saline 
(CD3
+
) 
G-CSF 
(CD3
+
) 
 Day 3 Day 7 Day 3 Day 7 
Young 
25194.6 ± 
6141.9 
 
23790.1 ± 
2568.1 
23721.5 ± 
2247.4 
26215.6 ± 
3371.0 
Aged 
26659.8 ± 
1563.8 
30960.4 ± 
5153.6 
36451.4 ± 
4798.5 
39230.1 ± 
4814.8 
 
No differences were observed in number of infiltrating T cells (CD3
+
) at days 3 and 7 
after injury and infection between young and aged mice. T cell numbers were not 
significantly affected by treatment with G-CSF. Data are shown as mean ± SEM; N=7-14 
per group. Data are not significantly different by one-way ANOVA. 
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No-age dependent effects of local G-CSF treatment on circulating leukocytes 
 To eliminate the possibility that local, s.c. G-CSF was inducing changes in the 
peripheral blood pool, we evaluated the frequency of circulating neutrophils in young and 
aged mice given saline or G-CSF injections (Figure 21). As reported previously 
(Brubaker et. al 2012, manuscript submitted), aged mice exhibited heightened levels of 
circulating neutrophils at day 3 compared young mice (Figure 21B, p<0.5), and this was 
not altered by G-CSF administration. This age-dependent elevation in the frequency of 
peripheral blood neutrophils persisted out to day 7 (Figure 21C, p<0.05). The frequency 
of CXCR2
+
 neutrophils in circulation was mildly increased in aged mice in both 
treatment groups at days 3 and 7 compared to young animals (Figure 21D-E, p<0.05). 
Again, G-CSF treatment did not impact the age-dependent difference in the frequency of 
CXCR2
+
 neutrophils. Similar to our previous study, aged animals exhibited elevated 
expression of CXCR2 at day 3 compared to young animals (Figure 21F, p<0.05), and G-
CSF did not impact the MFI of CXCR2 in either young or aged mice. No age- or G-CSF-
dependent differences in CXCR2 expression on circulating neutrophils were observed at 
day 7 (Figure 21G). 
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Figure 21. Local G-CSF does not alter the circulating neutrophil pool in aged mice. 
Whole blood was analyzed by flow cytometry to determine the percentage of circulating 
neutrophils and expression of the chemotatic receptor CXCR2. (A) Gating strategy for 
neutrophils (F4/80
-
Gr-1
+
) in whole blood by flow cytometry. Percentage of circulating 
neutrophils in peripheral blood in young (gray bars) and aged (white bars) mice at day 3 
(B) and day 7 (C). Frequency of CXCR2
+
 neutrophils in peripheral blood at day 3 (D) 
and day 7 (E). Expression of CXCR2 on peripheral blood neutrophils at day 3 (F) and 
day 7 (G). Data are shown as mean ± SEM, *p<0.05 compared to young saline, ‡p<0.05 
compared to young G-CSF and §p<0.05 compared to young with the same treatment by 
one-way ANOVA; N=7-14 per group. 
Day 3 Day 7 
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Summary 
 Herein, we have demonstrated that one administration of s.c. G-CSF 30 minutes 
following cutaneous wound infection with S. aureus promotes bacterial clearance in an 
age-dependent manner. The observed reduction in wound bacterial burden at day 3 and 7 
in G-CSF-treated aged mice was associated with increased neutrophil accumulation. 
Other laboratories have shown that G-CSF treatment can enhance age-related deficits in 
neutrophil chemotaxis. Previously, we have reported that neutrophils from aged mice 
demonstrate hyperchemokinesis but impaired directional motility in vitro. In vivo studies 
confirmed that neutrophils from aged mice have a reduced migratory response toward s.c. 
KC (Brubaker et. al 2012, manuscript submitted). We hypothesize that G-CSF restores 
these chemotatic defects in aged mice, enhancing neutrophil recruitment and helping 
reduce infection at the wound site in aged mice.  
Furthermore, G-CSF enhanced wound closure in aged animals as compared to 
young. Reports in aged mice indicate that i.p. G-CSF administration augments neutrophil 
recruitment and promotes wound closure in aseptic models of wound healing (49). The 
necessity of neutrophils for improved wound healing in these studies was confirmed by 
direct application of peritoneal derived neutrophils to the wound site. Together, these data 
suggest that neutrophils are required for wound closure in aged mice, and, in the setting 
of wound infection, increasing neutrophil recruitment promotes resolution of wound 
infection in aged mice.  
We did not observe any systemic effects of G-CSF on the peripheral blood pool. 
Local, one-dose administration of G-CSF did not significantly enhance the frequency of 
circulating neutrophils or the expression of their primary chemotatic receptor CXCR2. As 
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the effect of G-CSF appears to be localized to the wound site in our studies, these data 
support the potential use of local G-CSF as therapeutic intervention with limited systemic 
side effects. Future work to elucidate the mechanism by which G-CSF exerts these age-
dependent effects will develop our understanding of the aging innate immune system and 
may reveal therapeutic potential for G-CSF in the wound care setting. 
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CHAPTER 5 
AGE DOES NOT IMPACT ANTIMICROBIAL PEPTIDE EXPRESSION IN A 
MODEL OF CUTANEOUS WOUND INFECTION  
 
Abstract 
Antimicrobial peptides are small cationic molecules that are able to promote bacterial 
killing via interactions with the bacterial membrane, leading to membrane destabilization 
and bacterial lysis. In murine studies, mouse -defensin-3 (mBD3), mBD14, cathelicidin 
related antimicrobial peptide (CRAMP) and Reg3 have been shown to possess 
bactericidal activity against S. aureus. Considering the growing interest in these 
molecules as potential therapeutic targets in the setting of infection, we evaluated the 
impact of advanced age on cutaneous AMP expression following S. aureus wound 
infection in young (3-4 month) and aged (18-20 month) BALB/c mice. At days 1-10 after 
injury and infection, mice were sacrificed and AMP expression was evaluated by RT-
PCR and immunofluorescence. Age-dependent differences in mRNA levels of mBD3, 
mBD14 and CRAMP were variable between studies at day 1, with no age-related 
difference being observed at later time points. In three replicate studies, Reg3 was 
suppressed in aged animals as compared to young following injury and infection at day 1. 
By immunofluorescence, levels of mBD3 expression were low in uninjured skin in young 
and aged mice. After injury and infection at day 1, young animals had a marked increase 
in mBD3 expression along the wound edge. Aged animals failed to upregulate mBD3 
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protein levels as seen by immunofluorescence. TLR2 is a known regulator of AMP 
expression and the frequency of TLR2
+
 cells in aged mice was reduced as compared to 
young. There were no observed differences in the frequency of TLR2
+
 keratinocytes 
following injury, or in the MFI of TLR2. These data suggest that age-related differences 
in the AMP response are variable in our model of cutaneous S. aureus wound infection. 
In particular, levels of mBD3 and mBD14 mRNA are contradictory between studies. 
While Reg3 seems to be consistently decreased at the mRNA level in aged mice, further 
studies to validate these differences at the protein levels should be considered.  
 
Introduction 
The failure to effectively heal wounds is estimated to account for over 25 billion 
in US health care costs, and is augmented by the increasing prevalence of diabetes and 
obesity (151). The growing elderly population is a major contributor to the elevated 
prevalence of these chronic conditions, and they are also a major patient population 
afflicted with chronic wounds (119, 151, 159). Moreover, aging is associated with a 
precipitous decline in immune function that further compounds the delayed wound 
closure and heightened risk of infectious complications in the elderly (64, 160, 161). In 
healthy, non-aged patients, S. aureus infection accounts for 30% of surgical site 
infections as compared to 50% in aged patients, suggesting a penchant of this Gram-
positive bacterium for the immunocompromised (159). Antimicrobial peptides, such as 
defensins and cathelicidins, are small cationic molecules that are able to promote 
bacterial killing via interactions with the bacterial membrane, leading to membrane 
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destabilization and bacterial lysis (13). Previously, mouse b-defensin-3 (mBD3), the 
homolog to human -defensin 2 (hBD2), and mBD14, the ortholog to hBD3, have been 
shown to be induced following injury or infection and to possess bactericidal activity 
against S. aureus (15, 16, 134, 137, 201). Cathelicidins, like defensins, have also been 
show to play critical roles in wound repair and infection. Namely, loss of CRAMP is 
associated with increased susceptibility to infection and delayed wound closure in murine 
models. More recently, the Reg family of AMPs are emerging as another important 
antimicrobial family at the level of the skin and lung. Within this AMP family, Reg3 is 
an AMP that is regulated by IL-22, and is most commonly discussed in the context of gut 
homeostasis and bacterial clearance (202, 203). While few publications discuss the role 
of the Reg family in skin or any tissue other than the gut, IL-22 has been shown to be a 
player in skin inflammation [reviewed in (204)]. Recent data has also implicated Reg3 
in methicillin resistant S. aureus (MRSA) pneumonia. Despite the knowledge that these 
AMPs are important in wound healing and resolution of infection, to our knowledge the 
impact of aging on cutaneous AMPs has not been examined.  
As a gram-positive organism, the host response to S. aureus is driven in part by 
recognition via the TLR2 pathway in epidermal keratinocytes and innate immune cells 
(16, 98, 181, 205-207). Increased susceptibility to S. aureus infection is related to loss of 
TLR2 (98) by affecting neutrophil recruitment to the infection site (181) and through 
decreased expression of cutaneous AMPs in response to infectious challenge (16, 208). In 
addition to evaluating AMP expression, we sought to determine if differences in 
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keratinocyte TLR2 expression could contribute to potential age-related differences in 
antimicrobial peptide levels. 
We examined AMP levels in young and aged mice following cutaneous wound 
infection with S. aureus. Levels of mBD3, mBD14 and CRAMP yielded inconclusive 
results concerning an age-dependent change in these molecules. However, Reg3 was 
consistently suppressed in aged mice after injury and infection as compared to young. 
These data suggest that Reg3 levels may be reduced with aging; however, further studies 
should be conducted to more conclusively evaluate the impact of age on AMP expression 
following injury and infection.  
 
Materials and Methods 
Animal Model 
3-4 month old (young) and 18-20 month old (aged) BALB/c mice (Charles River/NIA, 
Kingston Facility, Stony Ridge, NY) were utilized to determine age-dependent 
differences in response to cutaneous wound injury and infection (Figure 5). All animal 
studies were approved and performed with strict accordance to the regulations established 
by the Loyola University Chicago Animal Care and Use Committee. Following 
acclimation at Loyola’s Animal Care Facility, young and aged mice were subjected to 
dorsal excisional cutaneous injury as previously described (175). Briefly, mice were 
administered 100 mg/kg ketamine and 10 mg/kg xylazine i.p. followed by i.p. saline to 
ensure systemic distribution of the anesthetic. Once the mice no longer responded to firm 
pressure applied to their hind limb, their dorsum’s were shaved and cleansed with ethanol 
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pads. Mice were then subjected to 6 dorsal full-thickness (skin and panniculus carnosa) 
cutaneous wounds with a 3 mm dermal punch biopsy (Acuderm, Ft. Lauderdale, FL). 
Immediately after injury, mice received ~10
3
 CFU/10uL of S. aureus and were returned 
to their cages on heating pads. A low inoculum of bacteria was chosen to prevent sepsis 
which is known to negatively impact wound healing (176). S. aureus Newman strain was 
grown overnight in TSB at 37
o
C under constant agitation. The next day, 1 mL of S. 
aureus in TSB was resuspended in 2mL fresh TSB and incubated at 37
o
C for 2 hours to 
ensure mid-logarithmic growth at the time of application to cutaneous wounds. Bacterial 
concentration (CFU/mL) was determined by absorbance at 600 nm and the final 
inoculum confirmed by back-plating on MSA (BD Diagnostics, Sparks, MD). 
Mice were sacrificed at days 1, 3, 7 and 10 after injury and infection. Wounds 
were excised and examined for AMPs via RT-PCR and immunofluorescence as described 
below. Two additional wounds, or two 5 mm punches of uninjured skin, were used to 
evaluate keratinocyte expression of TLR2. 
 
RT-PCR 
Following sacrifice, one wound was excised with a 5 mm punch biopsy and RNA 
was extracted using the Qiagen RNeasy Mini Kit (Qiagen, Valencia, CA). RNA was 
quantified using a Nanodrop Spectrophotometer ND-1000 (Thermo Scientific, 
Wilmington, DE) and cDNA synthesized using the iScript cDNA Synthesis Kit (BioRad, 
Hercules, CA). Quantitative RT-PCR was performed with the Applied Biosystems 7500 
Fast Real-Time PCR system, using specific TaqMan Expression Assays (Applied 
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Biosystems) for mBD3, mBD14, CRAMP, Reg3γ, K14 and -actin. Values were then 
normalized to -actin expression via the ΔΔCT method. For re-expression to K-14, each 
data set was normalized to -actin, and then expressed as the normalized gene of interest: 
normalized K14. 
 
Immunofluorescence 
Following sacrifice, a 5mm punch biopsy was used to removed the injured tissue 
and tissue borders. The skin was frozen in OCT, sectioned at 0.7 microns and frozen. At 
the time of analysis, slides were thawed overnight at room temperature in a humidified 
chamber and then fixed in 4% paraformaldehyde for 15 minutes. Slides were washed 3 
times with PBS, blocked with 10% BSA with 3% normal goat serum in PBS for 1 hour 
and stained overnight at 4
o
C with rabbit anti-human mBD2 with known cross-reactivity 
to mBD3. The following day, slides were washed 3 times with PBS and stained with goat 
anti-rabbit-Alexa-488 for 1 hour. Slides were washed three times in PBS and coversliped 
using VECTASHEILD mounting media with DAPI for nuclear staining (Vector 
Laboratories, Burlingame, CA). Fluorescent images were captured using a Zeiss Axiovert 
200 microscope (Zeiss, Thornwood, NY).  
 
Skin Cell Isolation and Flow Cytometry 
Single cell suspensions of wound cells for flow cytometry were generated as 
previously described (177). At days 1-10 after injury and infection, animals were 
euthanized, pelts removed and wounds excised using a 5 mm punch biopsy. Two diced 
110 
 
wounds were incubated overnight at 4
o
C in RPMI 1640 culture media (Gibco, Grand 
Island, NY) containing 10% FBS (Hyclone, Logan, UT), 2 mM L-glutamine (Gibco, 
Grand Island, NY), 1% penicillin/streptomycin (Gibco, Grand Island, NY), 2 mg 
gentamycin sulfate (Mediatech Inc, Manassas, VA) and 0.3 mg dispase II (Roche 
Diagnostics, Indianapolis, IN). Tissue pieces were then removed and subjected to further 
enzymatic digestion with 1 mg collagenase from Clostridium histolyticum type 1A 
(Sigma-Aldrich, St. Louis, MO), 1.2 mg DNAse I from bovine pancreas Grade II (Roche 
Diagnostics, Indianapolis, IN), 1 mg hyaluronidase from bovine testes type 1-S (Sigma-
Aldrich, St. Louis, MO), in RPMI 1640 with 5% FBS, 2 mM L-glutamine, 1% 
penicillin/streptomycin, gentamycin and magnesium chloride hexahydtrate for 2 hours at 
37
o
C. After two hours, these solutions were combined and adherent cells were treated 
with Accutase (eBioscience, San Diego, CA) for 8 minutes at 37
o
C followed by vigorous 
pipetting. Single cells suspensions were filtered through at 70 m filter to remove debris. 
Cells were washed and adjusted to 1x10
6
/mL. Wound cells were blocked for 20 minutes 
with FcBlock (anti-CD16/CD32, eBioscience) and rat IgG (Jackson ImmunoResearch, 
West Grove, PA), and then stained with APC-EpCAM (eBioscience, San Diego, CA), 
and PE-TLR2 (eBioscience, San Diego, CA). Cells were washed twice and then 
resuspended in flow buffer (1% BSA (Sigma-Aldrich, St. Louis, MO), 0.1% sodium 
azide and 2mM EDTA in PBS). Events were collected on the FACS LSR Fortessa (BD 
Biosciences, San Jose, CA) and data were analyzed by FlowJo Software (Tree Star Inc, 
Ashland, OR). Fluorescence minus one control staining and single color controls were 
used to determine positive staining. EpCAM
+
 cells were considered keratinocytes. 
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Statistical analysis 
Data are shown as mean ± SEM of each group. Data were analyzed by Student’s t test or 
one- way or two-way ANOVA with Tukey’s or Bonferroni post-hoc tests, respectively, 
where appropriate using GraphPad Prism 5 (GraphPad, La Jolla, CA). A value of p ≤0.05 
was considered significant. 
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Results 
mRNA levels of cutaneous antimicrobial peptides: mBD3, mBD14 and CRAMP 
To evaluate the impact of advanced age on AMP expression following cutaneous 
injury and infection, we examined mRNA levels of mBD3, mBD14, CRAMP and Reg3. 
Data from our first experiments suggested a lack of induction of mBD3 and 14 at day 1 
following injury and infection in aged mice as compared to young, with no age-related 
differences noted in mRNA levels of CRAMP (Figure 22A-C). At days 3 and 7 after 
injury and infection, there is a trend towards elevated mBD3 mRNA levels in aged mice 
as compared to young in two replicate experiments, but these data were not significant. 
No consistent difference between age groups were observed for mBD14 at these later 
time points (Figure 22D-E).   
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Figure 22.  Cutaneous antimicrobial peptide expression in young and aged mice 
following cutaneous S. aureus infection. Skin was isolated from young (gray bars) and 
aged (white bars) mice pre- and post-injury and infection. RNA was isolated from wound 
homogenates and gene expression of mBD3, mBD14 and CRAMP were determined by 
RT-PCR. (A-C) Relative gene expression of mBD3, mBD14 and/or CRAMP from three 
independent experiments in uninjured skin and at day 1 following cutaneous wound 
infection. (D-E) Relative gene expression of mBD3 and mBD14 at days 3, 7 and 10 after 
injury and infection from two independent experiments. Data are expressed as fold 
change compared to young sham and shown as mean ± STDEV (A) or SEM (B-E); 
*p<0.05 by Student’s t-test. (A) N=2-3 per group; (B) N=3-5 per group; (C) N=3-4 per 
group; (D-E) N=3-6 per group. 
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These data suggested a lack of induction of mBD3 and mBD14 at day 1 following injury 
and infection in aged mice as compared to young, suggesting a plausible mechanism for 
the elevated bacterial colonization and delayed leukocyte recruitment observed in aged 
animals. To determine if differences at the mRNA levels translated into differences at the 
protein level mBD3 protein expression at day 1 post injury and infection by 
immunofluorescence (Figure 23). In intact, uninjured skin obtained from young and aged 
sham mice, the levels of mBD3 were very low (Figure 23A-B). At day 1 after cutaneous 
wound infection, aged mice demonstrated a lack of induction of mBD3 along the wound 
border as compared to young mice (Figure 23C-D). These images are representative of 5 
animals per group from the experiment shown in Figure 22B. 
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Figure 23.  Fluorescent microscopy of mBD3 expression following cutaneous wound 
infection in young and aged mice. Uninjured skin and cutaneous wounds excised at day 
1 after injury were sectioned, fixed, blocked and then stained overnight at 4
o
C with rabbit 
anti-hBD2. Slides were then incubated with goat anti-rabbit AF488 (green) and DAPI 
(blue). Young sham (A), aged sham (B), young wound infection (C) and aged wound 
infection (D). Red arrows indicate the wound margin. Note: intense accumulation of 
green dye in a circular/oval shape in A-C is associated with hair follicles. Fluorescent 
images were acquired on a Zeiss Axiovert 200. Images representative of N=5 animals per 
group from the experiment shown in Figure 22B.
117 
 
As the relative level of mRNA expression was variable between experiments, an 
additional experiment was performed to evaluate mBD3 and mBD14 mRNA levels. 
Wounds were analyzed by RT-PCR for mBD3 and mBD14, and in contrast to previous 
experiments, mBD3 expression was elevated in aged mice as compared to young (Figure 
24A, *p<0.05). No induction of mBD14 was observed, similar to Figure 22C (Figure 
24A). After consideration of these data, another experiment with larger animal numbers 
was conducted to evaluate mBD3 and mBD14 at day 1 post injury and infection. These 
data paralleled the data shown in Figure 24A. At day 1 following cutaneous S. aureus 
infection, aged mice demonstrated elevated expression of mBD3 compared to their 
younger counter parts (Figure 24B, *p<0.05). While mBD14 was induced in this study, 
the relative expression of mBD14 was comparable between young and aged mice (Figure 
24B). These data are in vast contrast to the first three studies, and have made it difficult 
to determine the role defensins may play in the age-dependent differences observed in 
our model.   
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Figure 24. Cutaneous antimicrobial peptide expression in young and aged mice, 
additional experiments. In two additional replicate experiments, skin was isolated from 
young (gray bars) and aged (white bars) mice pre- and post-injury and infection. RNA 
was isolated from wound homogenates and gene expression of mBD3 and mBD14 were 
determined by RT-PCR (A-B). Data are expressed as fold change compared to young 
sham and shown as mean ± SEM; *p<0.05 by Student’s t-test. (A) N=3-6 per group; (B) 
N=4-10 per group. 
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In an effort to reconcile these divergent data, and to determine the relative amount 
of each AMP to keratinocytes in our samples, these data were re-expressed to K14, a 
keratinocyte marker (Figure 25). Re-expression of data to K14 did not significantly alter 
the trends seen in previous experiments, and suggest to conclusive age-dependent 
difference in mBD3 or mBD14 levels. To confirm our protein expression previously 
observed by IF, mBD3 and mBD14 ELISAs were purchased to quantify age-dependent 
differences. However, these ELISAs failed to develop and similar problems with two 
subsequent ELISA kits from this company were noted.  Taken together our data remain 
inconclusive regarding the expression of mBD3 and mBD14 after cutaneous injury with 
advanced age. 
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Figure 25.  Cutaneous antimicrobial peptide expression relative to K14 in young and 
aged mice.  Skin was isolated from young (gray bars) and aged (white bars) mice pre- 
and post-injury and infection. (A-B) Gene expression of mBD3 and mBD14 re-expressed 
relative to K14 and shown as fold change compared to young sham with mean ± SEM; 
*p<0.05 by student’s t-test; N=3-5 per group. 
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Reg3 expression following cutaneous S. aureus wound infection 
Reg3 is another AMP regulated by IL-17 and -22, and has been shown to play a 
role in MRSA infection and tissue injury (REFS). Following cutaneous injury and 
infection at day 1, we observed a suppression in Reg3 expression in aged animals 
relative to young in three replicate experiments (Figure 26, p<0.05). These differences 
were maintained after re-expression of the data to K14 (Figure 27). While these studies 
suggest that Reg3 mRNA levels may be reduced in aged animals compared to young 
following S. aureus wound infection, further work to confirm these studies at the protein 
level should be conducted.  
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Figure 26. Reg3 gene expression in young and aged mice. Skin was isolated from 
young (gray bars) and aged (white bars) mice pre- and post-injury and infection. RNA 
was isolated from wound homogenates and gene expression of Reg3 was determined by 
RT-PCR. Data are expressed as fold change compared to young sham and shown as mean 
± SEM; (A) N= 4-10 per group, **p<0.01 versus young sham, *p<0.05 versus young 
wound+infection by one-way ANOVA; (B) N=4-7 per group, *p<0.05 versus young 
sham, **p<0.01 versus young wound+infection by one-way ANOVA; (C) *p<0.05 
versus young wound+infection by Student’s t-test, N= 2-5 per group. 
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Figure 27. Reg3 gene expression relative to K14 in young and aged mice. Skin was 
isolated from young (gray bars) and aged (white bars) mice pre- and post-injury and 
infection. RNA was isolated from wound homogenates and gene expression of Reg3 and 
K14 were determined by RT-PCR. Data are re-expressed relative to K14 and shown as 
fold change compared to young sham with mean ± SEM.  N= 4-10 per group, **p<0.01 
versus young sham, *p<0.05 versus young wound+infection by one-way ANOVA. 
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TLR2 and CD14 expression on keratinocytes as regulators of AMP expression 
TLR2 is the pattern recognition receptor that aids in recognition of the S. aureus 
via homodimerization, or heterodimerization with either TLR1 or TLR6. Binding of S. 
aureus to TLR2 results in recruitment of CD14 and initiation of the MyD88 dependent 
pathway, resulting in activation of NF-B and the innate immune response (98, 205). 
Moreover, TLR2 expression on keratinocytes has been shown to play a role in induction 
of defensins (16).  Expression of TLR2 on keratinocytes was examined by flow 
cytometry (Figure 28A). The epithelial cell population was determined by using the 
surface marker epithelial cellular adhesion molecule (EpCAM) (209).  The frequency of 
EpCAM
+
 cells did not differ between uninjured young and aged mice (Figure 28B). A 
reduction in the frequency of EpCAM
+
TLR2
+
 cells found in injured skin from aged mice 
was observed (Figure 28C, *p<0.05), though no differences were seen in TLR2 
expression between the two age groups prior to injury and infection (Figure 28D).  
Following cutaneous wound infection, the frequency of EpCAM
+
 cells was decreased in 
both young and aged animals, however no differences were observed between age groups 
(Figure 28E). Similar to uninjured young and aged mice, no age-associated differences 
in the frequency of EpCAM
+
TLR2
+ 
cells or the MFI of TLR2 on EpCAM
+
TLR2
+ 
cells 
were observed (Figure 28F-G). 
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Figure 28. Keratinocyte expression of TLR2 pre- and post-cutaneous wound 
infection. Expression of TLR2 was determined by flow cytometry with EpCAM
+
 cells 
being considered the keratinocyte and epithelial cell population (A).  (B) Frequency of 
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EpCAM
+
 cells in young (circles) and aged (squares) mice prior to injury and infection. 
(C) Frequency of EpCAM
+
TLR2
+
 cells in young and aged mice in uninjured skin. (D) 
MFI of TLR2 on EpCAM
+
TLR2
+
 cells prior to injury and infection. (E) Frequency of 
EpCAM
+
 cells at days 1 and 3 after injury and infection. (F) Frequency of 
EpCAM
+
TLR2
+
 cells following cutaneous wound infection at days 1 and 3. (G) MFI of 
TLR on EpCAM
+
TLR2
+
 cells after injury and infection. Data are shown as mean ± SEM, 
N=4-6 per group,*p<0.02. 
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No differences in the frequency of EpCAM
+
TLR2
+
CD14
+ 
cells were noted between 
young and aged mice prior to injury or at day 1 post injury (Figure 29A+C). The MFI of 
CD14 on TLR2
+
 keratinocytes was similar between young and aged uninjured mice, 
however an increase in the MFI of CD14 was seen in aged animals compared to young at 
1 day after injury and infection (Figure 29B+D, p<0.05). These data suggest that age-
depended difference in TLR2 levels in uninjured keratinocytes could contributed to 
increased susceptibility to Gram-positive infection with advanced age; however, 
differences in TLR2 or CD14 on keratinocytes after injury and infection do not play a 
role in altered resolution of wound infection in aged mice. 
128 
 
A B
C D
*
Day 1
F
re
q
u
e
n
c
y
 o
f 
C
D
1
4
+
 C
e
ll
s 
o
f
E
p
C
A
M
+
/T
L
R
2
+
  
(%
)
Young Aged
0
10
20
30
40
50
Uninjured
M
F
I 
C
D
1
4
Young Aged
0
500
1000
1500
2000
2500
Day 1
M
F
I 
C
D
1
4
Young Aged
0
5000
10000
15000
Uninjured
F
re
q
u
e
n
c
y
 o
f 
C
D
1
4
+
 C
e
ll
s 
o
f
E
p
C
A
M
+
/T
L
R
2
+
  
(%
)
Young Aged
0
20
40
60
80
100
 
Figure 29. Expression of CD14 on TLR2
+
EpCAM
+
 cells pre- and post-cutaneous 
wound infection. Expression of CD14 and TLR 2 were determined by flow cytometry 
with EpCAM
+
 cells being considered the keratinocyte and epithelial cell population.  (A) 
Frequency of CD14
+
 cells within the EpCAM
+
TLR2
+
 population in young (circles) and 
aged (squares) mice prior to injury and infection. (B) MFI of CD14 on 
EpCAM
+
TLR2
+
CD14
+
 cells in uninjured skin. (C) Frequency of CD14
+
 cells within the 
EpCAM
+
TLR2
+
 population at day 1 after injury and infection. (B) MFI of CD14 on 
EpCAM
+
TLR2
+
CD14
+
 cells at day 1 after injury and infection. Data are shown as mean 
± SEM, N=4-6 per group,*p<0.02.   
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Summary 
Following S. aureus wound infection we observed varying degrees of induction of 
mBD3, mBD14 and CRAMP in young and aged animals. Interestingly, it appears that 
peak levels of these AMPs occurred between days 3 and 7. Generally, AMPs are 
considered early mediators of the innate immune response to cutaneous wound injury; 
however, the infection may be generating a protracted AMP response in our system. As 
we did not observe consistent differences in mBD3, mBD14 or CRAMP at the mRNA 
level, we cannot conclude the impact of age on these mediators. To our knowledge, the 
only published study that examined the effect of age on AMP expression examined levels 
of hBD2, the human homolog to mBD3, in uninjured skin from young and elderly 
subjects. In this study, basal levels of hBD2 were reduced in uninjured skin from elderly 
subjects as compared to young. We did not observe this same trend in uninjured murine 
skin. In regards to TLR2 expression, various TLRs on differing cell types have been 
showed to be affected by age. We did observe a reduction in the frequency of TLR2
+
 
cells with age prior to injury, but following injury and infection these differences were no 
longer observed. As TLR2 is important in the immediate host response to Gram-positive 
infection, this basal decrease in TLR2 expression with age may enhance susceptibility to 
infection associated with aging. Future work to evaluate TLR1/6 expression, the two co-
receptors for TLR2, in aging skin would strengthen our knowledge regarding cutaneous 
TLRs and their role in vulnerability to S. aureus infection with age. Additional work to 
evaluate how aging alters AMPs following injury and infection should also be examined. 
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CHAPTER 6 
DISCUSSION 
In review, we have developed a murine model of cutaneous wound infection with 
S. aureus that allows for evaluation of age-dependent differences in the immune response 
to infection and tissue injury. Herein, we demonstrated that advanced aged is associated 
with elevated bacterial colonization at early time points, and persistent infection out to 
day 10 post wound infection. These findings parallel clinical observations in elderly 
patients as they have elevated rates of S. aureus infection, which correlates with a 
prolonged length of hospital stay and increased hospital costs (121, 159, 174). Other 
murine models of infection, such as pneumonia, also report an increased bacterial burden 
in aged animals (192). Moreover, we observed that wound closure was protracted in aged 
animals. Studies in murine models of uninfected wounds report similar delays in wound 
closure with advanced age (49, 63); however, the time to closure was reduced as 
compared to infected wounds from our animals. Interestingly, despite the persistent 
elevation in bacterial burden observed in the aged mice, the delay in wound closure was 
not perturbed to a similar degree. This may be due to the relatively low inoculum used in 
this study to limit septic events known to alter wound healing (176). Alternatively, the 
persistence of bacteria in the wound bed may be altering other components of wound 
repair such as collagen deposition which aids in restoration of the dermal matrix (63, 
210). While not evaluated in this study, further work examining how bacterial infection 
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alters the wound collagen matrix and tensile strength may help elucidate 
mechanisms underlying the elevated rate of wound dehiscence in elderly patients. 
An important factor in mediating the host response to infection is early 
recognition of foreign pathogens by host immune cells. Following tissue injury, local and 
recruited leukocytes act to detect evolutionary conserved PAMPs via pattern recognition 
receptors (PRRs). TLR2 is a PRR which specifically recognizes Gram-positive bacteria 
via homodimers or heterodimers with TLR1 and TLR6 (211). Activation of TLRs in 
innate immune leukocytes results in NF-kB dependent production of pro-inflammatory 
mediators, helping to recruit additional leukocytes and promote antigen presentation to 
recruited adaptive immune cells (100, 182). Loss of TLR2, or mediators of TLR 
signaling, have been associated with increased susceptibility to S. aureus infection, as 
mice deficient in TLR2 or MyD88 demonstrated heightened levels of S. aureus 
bacteremia (98, 181, 183, 212). Thus, we chose to evaluate TLR2 expression on 
keratinocytes as well as resident and infiltrating leukocytes, as TLR2 is required to 
effectively eliminate S. aureus. In uninjured skin, aged mice had a reduced frequency of 
TLR2
+
 keratinocytes relative to young mice, though no difference in the MFI were noted. 
Similarly, we observed an age-dependent decrease in the absolute number of TLR2
+
 
resident tissue macrophages; however, no differences in expression or frequency of 
TLR2
+
 infiltrating wound neutrophils or macrophages were observed. Together, the 
reduction in the frequency of TLR2
+
 keratinocytes and resident macrophages may 
contribute to heightened vulnerability to infection with advanced age. Other aging studies 
have found variable results in regards to tissue macrophage TLR2 expression (74). While 
reports demonstrate that macrophage expression of one or all TLRs are reduced with 
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aging (74, 101, 192), previous studies from our own laboratory have demonstrated no 
change in peritoneal or splenic macrophage TLR2 and TLR4 expression (82). In 
circulating neutrophil populations, human studies suggest that expression of TLR2 and 
TLR4 are unaltered with age, though membrane-associated MyD88 was decreased with 
age after exogenous stimulation with LPS (45). Though not evaluated in our study, age-
associated alterations in mediators of TLR2 signaling, such as MyD88, Toll-interleukin 1 
receptor domain containing adaptor protein (TIRAP) or interleukin-1 receptor-associated 
kinase (IRAK), may dampen TLR2 responses in aged individuals and contribute to 
delayed resolution of bacterial infection (100, 213, 214).  
TLRs are also known to initiate the signaling cascade that results in elevated 
AMP expression following cutaneous injury or infection. Despite reduced TLR 
expression in aged animals relative to young, we did not observed a basal reduction in 
AMPs levels with age. This is contrary to a study in humans in which hBD2, the homolog 
to mBD3, was reduced in skin from elderly subjects as compared to young. While no 
other studies have evaluated AMP expression following injury and infection in the setting 
of aging, our contradictory data suggest that further work should be conducted to 
elucidate if aging impacts these critical early mediators of the innate immune response. 
Particular attention to be paid to the Reg family, namely Reg3, as this appears to be 
most consistent in our studies and has been shown to be critical in other models of S. 
aureus infection. 
In addition to recognition of foreign microbes, neutrophils and macrophages that 
are recruited to the site of tissue injury play a critical role in phagocytosis and killing of 
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invading bacteria. Previous studies have reported that aging negatively impacts the ability 
of both neutrophils and macrophages to phagocytosis pathogens (46, 50, 120, 185, 186), 
though few have evaluated the phagocytic potential of leukocytes following recruitment 
in response to tissue injury or infection. Following cutaneous wound injury, no age-
dependent differences in wound neutrophil or macrophage phagocytosis were noted. 
Interestingly, studies in human neutrophils have reported an age-associated reduction in 
TREM-1 mediated phagocytosis and ROS generation that mediates bactericidal activity 
in human neutrophils (215). Furthermore, aging was associated with decreased FcRIII 
expression in circulating human neutrophils and this correlated with reduced 
phagocytosis (46). Though our observed differences in FcRIII did not contribute to 
differences in phagocytosis or bactericidal activity as reported in human peripheral blood 
neutrophils by Butcher et al., recent reports show that FcRII regulates FcRIII with 
functional effects on phagocytosis (216, 217). Given that we did not find a functional 
defect in our cell populations, we did not evaluate whether expression of FcRII, or other 
phagocytic pathways such as complement-mediated phagocytosis, were altered with 
advanced age. Moreover, that lack of age-related differences in neutrophil phagocytosis 
is in concert with other reports in mice that do not recapitulate the phagocytosis deficits 
observed in circulating human neutrophils (74). Our study extends these findings in 
rodent studies to demonstrate that even after recruitment to a specific tissue 
microenvironment, neutrophil phagocytosis is not impaired by advanced age.   
On the other hand, human and rodent studies more definitively agree that aging 
impairs macrophage phagocytosis (50, 185-187, 218), though some reports find no age-
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dependent phagocytic differences (74, 83). DiPietro et al. examined wound macrophage 
phagocytosis in young and aged mice with divergent results from those observed in this 
study. Following isolation of macrophages from subcutaneous implanted PVA sponges, 
phagocytosis was reduced ~40% in macrophages from aged mice relative to young mice 
(50).  While this study also examined the phagocytic potential of cells following 
recruitment to cutaneous tissue, it did so by implementing PVA sponges to isolate 
recruited macrophages (219). This environment is different than that created by the 
wound milieu of an excisional wound, and may account for the observed differences. It is 
also important to note that the wound cell isolation procedure and optimal conditions of 
the pHrodo-S. aureus phagocytosis assay may limit observing small age-dependent 
impairments of phagocytosis in either wound neutrophils or macrophages.  
Most significantly, our data supports the idea that advanced age alters the 
infiltration kinetics of innate immune cells following tissue injury and infection. 
Alterations in infiltration of these cells can impact several facets of wound healing. First, 
reduced recruitment of these phagocytes may directly contribute to heightened bacterial 
levels as these infiltrating phagocytes are critical in controlling infectious spread (193). 
Second, the age-dependent differences in the initial wave of neutrophil infiltration may 
affect recruitment of macrophages via secreted mediators that directly interact with 
macrophage chemokine receptors and the vascular endothelium (172, 220). A delay or 
reduction in macrophage accumulation, or alteration in macrophage phenotype, may 
further impair transition to the proliferative phase of wound healing, negatively impacting 
wound closure and restoration of the dermal matrix (118, 144, 221). Moreover, 
diminished macrophage function and/or numbers have been shown to delay wound 
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healing and decrease wound tensile strength (145, 147). Lastly, studies in aged mice 
suggest that there is a necessity for neutrophils in efficient wound healing with advanced 
age (26). However, these data call into question the accepted dogma of efficient wound 
healing. While macrophages are considered to be beneficial to wound healing, the role of 
neutrophils in sterile wound healing is controversial. Although neutrophils are required 
for eradication of invading organisms, gratuitous neutrophil accumulation can result in 
excessive ROS and elastase production, in turn exacerbating tissue damage and impeding 
wound healing (65, 160). Specifically, in fetal models of wound healing, there is a 
paucity of neutrophil recruitment and inflammation that is correlated with reduced scar 
formation (131, 222). Studies in young mice have also shown that neutrophil depletion 
may accelerate aseptic wound closure (140). Despite these findings, reports in the aging 
literature have demonstrated that even in the setting of sterile wound healing, ablation of 
the neutrophil population delays wound closure in aged animals (49). Importantly, 
increasing neutrophil numbers via i.p. administration of G-CSF enhanced rates of wound 
closure in aged mice to those observed in young mice (49). In the context of an infected 
wound, the necessity of neutrophil recruitment becomes increasingly paramount. 
Clinically, patients with reduced neutrophil function or numbers are at a heightened risk 
for chronic and repeated infections with catalase-positive bacteria, like S. aureus (43, 
184, 194). Thus, the decreased absolute numbers of neutrophils and macrophages in our 
model may not only contribute to bacterial colonization differences observed with age, 
but may also play a role in delayed wound resolution in aged animals. 
As mentioned previously, this weakened neutrophil response may alter the 
kinetics and subsequent leukocyte infiltration of wound healing in aged animals. 
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Recently, we reported that peripheral blood neutrophils from unmanipulated young and 
aged mice have a basal hyperchemokinesis but lack directional migration ex vivo (60). 
Other studies have supported that aging is correlated with neutrophil chemotatic defects 
(45, 74, 200). Here, we extend these findings to show that at increasing doses of KC in 
vivo, neutrophils from aged mice had a diminished migratory response to cutaneous 
tissue as compared to young. While we saw blunted chemotaxis to the CXCR2 ligand 
KC, we observed elevated CXCR2 expression on circulating neutrophils from aged 
animals. These data suggest that despite adequate expression of CXCR2, mediators of 
CXCR2 signaling may be impaired with age. For example, recruitment of -arrestin 2 to 
CXCR2 has been shown to be required for CXCR2 activation (191) and has been 
reported to be decreased in brain tissue of elderly humans (223). Alternatively, previous 
reports have demonstrated that high levels of KC promote CXCR2 receptor 
desensitization and impaired chemotaxis (25). Thus, it is plausible that the early peak in 
KC levels observed in aged mice acts to attenuate neutrophil recruitment despite bacterial 
infection in our aged animals.  These data extend our findings in our wound infection 
model, and suggest that neutrophil chemotaxis is perturbed in aged mice.  
Aging studies in aseptic wound models have shown that systemic G-CSF 
enhances neutrophil recruitment and reduces time to wound resolution in aged animals 
(49). While the role of neutrophils in aseptic wound healing has been questioned (65, 
140), patient populations that are at increased risk for infectious complications, such as 
aging or immunocompromised subjects,  demonstrate a necessity for neutrophil 
recruitment during wound repair (Brubaker et. al 2012, manuscript submitted). 
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Previously, we demonstrated that neutrophils from aged mice exhibit a migratory defect 
to the murine neutrophil CXCR2 ligand KC in vitro and in vivo (60). Moreover, we have 
observed neutrophil chemokine levels to be similar or elevated in wound homogenates 
and enhanced expression of CXCR2 on circulating neutrophils in aged mice (Brubaker et. 
al 2012, manuscript submitted). Together, these data suggest that age-associated 
alterations in the downstream CXCR2 signaling cascade may contribute to reduced 
neutrophil recruitment. G-CSF has been shown to mediate neutrophil migration to 
macrophage-inflammatory protein-2 (MIP-2), another CXCR2 ligand, via STAT3 
mediated induction of CXCR2 expression and regulation of CXCR2 signaling (224). 
Additionally, in vivo G-CSF has been shown to restore ex vivo neutrophil chemotaxis in 
aged rats (200) and following systemic trauma (225). Given these data, it is reasonable to 
suggest that enhancing neutrophil recruitment in aged mice may reduce bacterial 
colonization and wound closure. In the study by Nishio et al., G-CSF may not only be 
enhancing circulating neutrophil numbers but may aid in overcoming an age-related 
migratory defect by enhancing CXCR2 mediated signaling. Based on those data, we 
attempted to modulated neutrophil recruitment in aged mice via local, s.c. G-CSF 
administration. We demonstrated a beneficial effect of G-CSF treatment on resolution of 
infection and wound healing in aged mice following S. aureus wound infection. These 
reductions in our primary outcomes were associated with enhanced neutrophil 
recruitment to the wound site in aged mice following treatment with G-CSF at days 3 and 
7. G-CSF treatment did not affect wound macrophage or T cell numbers at days 3 and 7 
as compared to saline treated young and aged mice. While the precise mechanism 
remains unclear, we postulate that restoration of neutrophil recruitment in our model may 
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be through a G-CSF mediated restitution of CXCR2-directed signaling and chemotaxis in 
aged mice (Figure 30). G-CSF may act to stabilize CXCR2 signaling in aged animals by 
enhancing downstream factors such as STAT3 and Rap1 (26, 28, 224). Together this 
would promote upregulation and clustering of integrins, including LFA-1 and VLA-4, 
which interact with ICAM-1 and VCAM-1, respectively, on activated endothelium (26). 
Potentially, increased interactions between these molecules could enhance neutrophil 
firm adhesion and diapedesis, allowing increased neutrophil recruitment to sites of injury 
and infection in aged animals. To our knowledge, this is the first study to demonstrate the 
differential effects of G-CSF as a therapeutic modality in the setting of wound infection 
with advanced aged. Future work needs to be conducted to elucidate the precise 
mechanism by with G-CSF exerts these age-dependent effects.
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Figure 30. Proposed mechanism: G-CSF treatment restores age-dependent 
differences in neutrophil recruitment by enhancing signaling involved in neutrophil 
chemotaxis. We postulate that G-CSF acts to stabilize signaling downstream of CXCR2. 
Potentially, G-CSF may act to enhance STAT3 or Rap1 activation, increasing 
upregulation and clustering of integrins that facilitate firm adhesion to the activated 
endothelium. Conceptually, this would promote elevated adhesion and transmigration of 
neutrophils to the site of injury and infection. Further studies are needed to determine if 
this is the mechanism by which G-CSF exerts age-dependent effects in our model. 
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G-CSF is a known modulator of granulopoiesis and hematopoietic stem cell 
mobilization as well as a regulator of neutrophil bone marrow emigration, survival, 
chemotaxis and phagocytosis (226-229). Currently, G-CSF (Filagrastim/PEG-
Filagrastim) is indicated for patients with congenital or iatrogenic neutropenias (230) and 
for donors prior to hematopoietic stem cell transplantation (231). Pre-clinical and clinical 
trials are underway to investigate the therapeutic potential of G-CSF in amyotrophic 
lateral sclerosis (232, 233), acute liver failure/alcoholic hepatitis (234), myocardial 
infarction (235), peripheral arterial disease (236) and diabetic foot infections (237, 238). 
Alongside our study, these reports provide novel indications for the expanded use of G-
CSF as therapeutic interventions.  
The studies using G-CSF in the setting of diabetic wound infection provide an 
interesting point of comparison to the data presented in this manuscript. Cruiciana et al. 
reviewed five randomized controlled trials with a total of 167 patients that added G-CSF 
to treatment regimens for patients with diabetic foot infections. Though one study 
reported a shorter time to resolution of infection and intravenous antibiotic use (239), the 
meta-analysis revealed that addition of G-CSF did not decrease the risk of infectious 
complications or enhance wound closure, but it did reduce the relative risk of lower limb 
surgical interventions and the hospital length of stay (237). Similar to advanced aged, 
neutrophil dysfunction and elevated risk of S. aureus infection are associated with 
diabetes (240). However, the studies above do not suggest a strong therapeutic benefit for 
G-CSF in diabetic patients. Diabetes is also associated with peripheral arterial disease 
(PAD) that may inhibit additional facets of wound healing which may not be modulated 
by G-CSF. Though not evaluated in our studies, aging is associated with alterations in 
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angiogenesis of local vasculature following cutaneous wound injury (63); however, this 
differs from the more extensive vascular compromise associated with diabetic PAD. 
Moreover, studies in db/db mouse models have actually demonstrated elevated neutrophil 
recruitment to sites of S. aureus infection in db/db mice (240). This is in contrast to our 
model, in which reduced neutrophil accumulation in aged mice was associated with 
delayed bacterial clearance and wound closure.  
Other studies do support a therapeutic benefit for G-CSF in prevention of 
infectious complications (241, 242). In patients undergoing esophagectomy for 
esophageal cancer, perioperative, s.c. G-CSF improved neutrophil effector functions and 
elevated circulating leukocyte counts (241). Infection rates and postoperative death were 
also reduced in the treatment groups as compared to historical controls (241). In a case 
report, daily G-CSF treatment in a neutropenic patient that developed a non-healing 
pharyngocutaneous fistula following radical laryngectomy promoted closure of the fistula 
where previous aggressive wound therapy failed (242). These papers support the use of 
G-CSF in infectious wound care settings in neutropenic patients. While no peripheral 
neutropenia was noted in our aged animals prior to G-CSF treatment, we did observe a 
local reduction in neutrophil numbers at the wound infection site in saline-treated aged 
mice that was restored following G-CSF administration.  
As bacterial strains, in particular S. aureus, continually evade our current 
antibiotic treatments, understanding how advanced age impairs the host immune response 
may allow us to target immunomodulatory mechanisms that will improve outcomes 
following cutaneous wound injury in elderly patients. While future work needs to be 
conducted to elucidate the mechanism by which G-CSF exerts these age-dependent 
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effects, our data highlights a putative indication for G-CSF treatment within the wound 
care setting in the elderly patient population as well as patients with local or systemic 
neutropenia. 
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